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Management of metabolic syndrome (MetS) may be enhanced by promoting patient 
engagement. Training health care providers in the conceptual and practical application of 
integrative patient centered care tools may promote patient lifestyle behaviors for better 
management of MetS. The purpose of this quantitative quasi-experimental study was to 
assess the impact of training providers in integrative patient centered care for patients 
with MetS. The biopsychosocial construct provided the conceptual framework for the 
study. Two groups of physicians were included; one received training in an integrative 
model (IM) while the second received no training and provided usual care (UC). 
Following training, patient disease biometrics and medication adherence were monitored 
for approximately four months. Due to a diminished sample size in the completer data 
set, an intention to treat (ITT) data set was created with baseline values brought forward. 
In the ITT set, BMI decreased significantly (p=0.005, d=0.18) with each group over time: 
(IM: 32.9 ± 7.3 Kg/m2  to 31.6 ± 6.8 Kg/m2) and (UC: 32.1 ± 6.7 to 31.5 ± 6.3 Kg/m2). 
However, there were no statistically significant differences between these two groups’ 
measures. In the completer set, BMI decreased significantly (p < 0.05, d=0.18) over time 
with the IM group, but not the UC group: (IM: 35.14 ± 7.9 Kg/m2 to 33.65* ±  7.62 
Kg/m2) and (UC: 32.4 ± 6.62 Kg/m2 and (32.4 ± 6.5 Kg/m2); indicating a possible 
relationship between the intervention training (IM) and improved health outcomes. Thus, 
providers are assisting patients with important lifestyle choices to better manage MetS, 
potentially leading to social change around improved patient health care behaviors and 
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Chapter 1: Introduction 
Understanding the impact of patient engagement on health outcomes of chronic 
disease patients is of critical interest due to escalating health care costs and an epidemic 
of chronic disease in the United States. The Centers for Disease Control and Prevention 
(CDC, 2011) stated the rates of chronic diseases such as obesity, cardiovascular disease, 
stroke, and cancer are increasing and account for 75% of the two trillion dollars spent on 
health care. This spending makes chronic disease the leading factor in current health care 
expenditures in front of technology, prescription drugs, and administrative costs (CDC, 
2011; Kaiser, 2012). To prevent chronic disease, researchers should examine the risk 
factors and how to mitigate them. Metabolic syndrome (MetS) is diagnosed in a person 
with three or more symptoms or precursors to chronic diseases such as cardiovascular 
disease, type 2 diabetes, and stroke (Dickerson, Smith, McNeal, & Ory, 2011; Ma & Zhu, 
2013). The symptoms include obesity, hyperglycemia, low cholesterol high-density 
lipoprotein (HDL), and high triglycerides or hyperlipidemia (Burghen, 2005; Ma & Zhu, 
2013). Dagogo-Jack, Egbuonu, and Edeoga (2010) indicated that health care providers 
should start chronic disease intervention treatment at the onset of MetS or before to 
decrease the cumulative effects of associated symptoms.  
Impact of Patient Engagement 
Even though there is abundant research on MetS, there is a gap in best practices 
on successful ways to treat and prevent these symptoms (Appel, Jones, & Kennedy-
Malone, 2004; Burghen, 2005; Dickerson et al., 2011; Ma & Zhu, 2013). There is limited 





centered care and how providers are or are not taught to interact with their patients. 
Recent research on combinations of factors indicated further study due to protocol-
specific limitations (Ampt et al., 2009; Brady, Solomon, Neu, Siberry, & Parekh, 2010; 
Burghen, 2005; Fifield et al., 2010; Graham, 2014; Jacobson & Gance-Cleveland, 2011; 
Karve & Hayward, 2010; Wiley et al., 2015; Xiang, Wethington, Onufrak, & Belay, 
2014). This limited research, with 50% focusing on pediatrics, has left a gap in 
understanding how integrative patient centered training may positively impact MetS 
symptoms in adults. The most influential factor for reducing cardiovascular and diabetic 
symptoms, which may be promoted by positive patient engagement, is ideal lifestyle and 
behavioral changes (Jacob & Serrano-Gil, 2010; Kones, 2013; Nield, 2008; Wolever et 
al., 2011). In addition to the gap in research, the concept of patient engagement has been 
poorly defined and has been interpreted and applied in nonstandardized ways by 
stakeholders across the health care industry. This is contributing to confusion regarding 
this complex concept that has the potential for effective application including improving 
self-health promotion, medication adherence, and health outcomes (Barello, Graffigna, & 
Vegni, 2012; Bertakis & Azari, 2011; Institute of Medicine, 2001).  
Gaps in understanding patient engagement indicate the need for ongoing research 
to further define and understand the various applications and impact of patient 
engagement on medication adherence and health outcomes (Barello et al., 2012; Bertakis 
& Azari, 2011; DiMatteo, Hays, & Sherbourne, 1992; Dunbar-Jacob & Mortimer-
Stephens, 2001; Institute of Medicine, 2001). Much qualitative and quantitative research 





concept means, and limited understanding of how it is used throughout the medical 
industry. Patient engagement is defined by the Agency for Healthcare Quality and 
Research (AHQR, 2011) as “an ongoing process in which patients take an active role in 
their own healthcare” and involves how factors such as “personal skills, motivation, and 
behaviors - affect an individual’s ability to effectively engage in care” (p. 1). Barello et 
al. (2012) described the confusion around the widely used term and recommended a 
multi-perspective approach such that various aspects are analyzed to include “interaction 
between its individual (i.e., emotional, cognitive and behavioral, etc.), relational (i.e., 
patient health providers, patient caregiver,...etc.), and organizational (i.e., type of health 
care settings,…role and attitude of health professionals, etc.), dimensions across the 
specificities of each single disease” (p. 7). Barello et al. determined that additional 
research is required to develop empirical evidence based on theoretical construct taking 
into account what factors affect patient engagement. Based on the lack of conformity 
around the meaning and use of the term patient engagement, research conducted to 
methodically define, develop, and establish practical and economically feasible 
application is necessary. This study addressed the effects of an integrative patient 
centered provider training protocol on integrative patient centered and whether there was 
an associated effect on medication adherence and health outcomes. Two groups of 
patients were compared: (a) providers trained on integrative patient centered care (the 







Patient engagement is defined by the Agency for Healthcare Quality and Research 
(AHQR, 2011) as “an ongoing process in which patients take an active role in their own 
healthcare” and involves  how factors such as “personal skills, motivation, and behaviors-
affect an individual’s ability to effectively engage in care” (para 1). Simmons, Wolever, 
Bechard, and Snyderman (2014) followed this definition with their systematic review of 
clinical trials on patient engagement. Out of 543 abstracts evaluated, only 10 trials met 
the researchers’ criteria that defined patient engagement as (a) understanding the 
importance of taking an active role in one’s health and health care; (b) having the 
knowledge, skills, and confidence to manage health; and c) using knowledge, skills and 
confidence to perform health-promoting behaviors (Simmons  et al., 2014, p. 3). 
Understanding what patient engagement is based on these criteria from the Agency for 
Healthcare Research Quality and a large systematic review provided a foundation for 
examining whether patient engagement was correlated with medication adherence and 
health outcomes. 
Problem Statement 
Understanding how to use patient engagement to promote positive lifestyle 
behaviors is key to improving health outcomes for MetS patients. Training health care 
providers on the conceptual and practical application of integrative patient centered 
engagement tools has not been studied as a method for patient engagement promotion. If 





correlate with improved patient engagement, it may encourage providers to empower 
their patients to practice motivated self-health care and medication adherence. 
Purpose of Study 
The purpose of this study was to assess how patient engagement in their health 
care influenced health outcomes (MetS symptom improvement based on associated 
biometrics) and medication adherence, defined as taking or not taking medication (noted 
on electronic health record (EHR) or patient reported). Results may be used to develop 
and implement practical and financially feasible practices that may promote improved 
health care outcomes, increased medicine adherence, and enriched patient provider 
engagement (Cox, 2011; Engel, 1977; Guarneri & Tager,, 2014; Simmons et al., 2014; 
Williams, Frankel, Campbell, & Deci, 2000).  
Nature of Study 
I used a quantitative quasi-experimental design with a time interval method 
employing a pre-intervention data capture (baseline) and post-intervention data capture at 
approximately four months post-intervention training. I performed repeated measures 
multivariate analysis of variance (MANOVA) (Campbell & Stanley, 1963; Creswell, 
2009; Frankfort-Nachmias & Nachmias, 2008). The influence of patient engagement 
factors on disease management outcomes biometrics (blood pressure, triglycerides, BMI, 
blood glucose: serum and A1c, and high density lipoproteins) and medication adherence 
(defined as taking or not taking) were compared between two patient groups within a 
health care clinical system. The intervention group received integrative patient centered 





training. The intent of the intervention group was to determine the effects of newly 
administered patient centered provider training on patients with MetS. I analyzed and 
compared the differences between groups. The outcomes of the integrative patient 
centered training can be compared to other patient engagement efforts to determine levels 
of effectiveness based on disease management outcomes and medication adherence. 
A patient engagement research predictor/independent variable (provider 
integrative patient centered care education) was analyzed to determine its influence on 
dependent variables (subsequent health outcomes and medication adherence). 
Research Questions (RQs) and Hypotheses 
RQ1: Is there a difference in disease biometrics outcomes (blood pressure, 
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins) 
in patients with MetS following implementation of a patient engagement provider 
training protocol in an integrative health clinic? 
H1n: There is no difference in disease biometrics outcomes (blood pressure, 
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins) 
in patients with MetS following implementation of patient engagement provider training 
protocol in an integrative health clinic. 
H1a: There is a difference in disease biometrics outcomes (blood pressure, 
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins) 
in patients with MetS following implementation of a patient engagement provider 





RQ2: Is there a difference in medication adherence (EHR noted or patient 
reported at clinical visit) in patients with MetS following implementation of a patient 
engagement provider training protocol in an integrative health clinic? 
H2n: There is no difference in medication adherence (EHR noted or patient 
reported at clinical visit) in patients with MetS following implementation of a patient 
engagement provider training protocol in an integrative health clinic. 
H2a: There is a difference in medication adherence (EHR noted or patient 
reported at clinical visit) in patients with MetS following implementation of a patient 
engagement provider training protocol in an integrative health clinic. 
Health outcomes and medication adherence were the dependent variables, and 
integrative patient centered engagement provider training was the independent variable.  
Conceptual Framework 
The biopsychosocial construct is based on mind/body medicine in which a 
person’s intrinsic capacities for disease prevention and healing are supported through 
integrating the understanding of their biology, psychology, and social influences into 
diagnosis and treatment; the biopsychosocial construct is often aligned with the patient 
centered approach to health care and delivery (Bausell & Berman, 2002; Cox, 2011; 
Engel, 1977; Fremont & Bird, 1999; Freudenreich, Kontos, & Querques, 2010; Klinkman 
& van Weel, 2011; Levin, 2009; Mauksch, 2005; Montori, Brito, & Murad, 2013; Moss, 
2003; Scherger, 2005; von Bertalanffy, 1950; Williams et al., 2000). “Biopsychosocial 
care is complex work. It requires an attitude of caring for the whole person in all 





Biopsychosocial care involves the provider listening to and engaging with the patient’s 
explanation of his or her illness and issues, and aligning that insight with discussion and 
treatment. This intentional provider-patient engagement takes into account the patient’s 
biology, psychology, and social influences that can impact symptoms and disease 
(Freudenreich et al., 2010; Gorgens, 2006; Montori et al., 2013).  
Systems theory was founded by von Bertalanffy (1950) and was developed into a 
more current version by Engel (1977), who discussed the biopsychosocial concept as the 
impossibility of understanding illness without understanding the internal and external 
environment from which the patient resides. This model is different from the 
conventional biomedical model of care in which disease is observed according to the 
biological symptoms that define it, and treatment of symptoms occurs through 
pharmaceuticals and surgery (Bausell & Berman, 2002; Engel, 1977; Fremont, & Bird, 
1999; Freudenreich et al., 2010; Gorgens, 2006; Levin, 2009). The biomedical model also 
stems from two reductionist concepts: it reduces a complex disease process down to a 
single factor, and mind-body dualism dictates separation of mental or behavioral issues 
from biological or somatic issues (Engel, 1977; Freudenreich et al., 2010; Gorgens, 
2006).  
My research approach was inclusive, involving both a biopsychosocial and 
biomedical understanding of the individual. The biomedical model was already in use 
and was the common ground from which to apply the integrative patient centered care 
training protocol. The integrative patient centered care training protocol comprised 





health care provider with the intention of facilitating patient engagement to inspire or 
motivate the patient to improve self-care behaviors and medication adherence.  
Operational Definitions 
Biopsychosocial: Taking into account the patient’s biology, psychology, and 
social influences that can impact symptoms and disease (Freudenreich et al., 2010; 
Gorgens, 2006; Montori et al., 2013). 
Clinical inertia: “Lack of treatment intensification in a patient not at evidence-
based goals for care. Clinical inertia is a major factor that contributes to inadequate 
chronic disease care in patients with diabetes mellitus, hypertension, dyslipidemias, 
depression, coronary heart disease, and other conditions” (O’Connor, Sperl-Hillen, 
Johnson, Rush, & Biltz, 2005, p. 1).  
Healthy behaviors: Include healthy nutrition, exercise, stress management, 
restorative sleep, and pursuit of happiness (Guarneri et al., 2014). 
Hemoglobin High A1c: ≤ 5.6 mg/dl. 
High body mass index (BMI): ≤ 30 kg/m2  is correlated with increased MetS and 
age (Beltrán-Sánchez, Harhay, Harhay, & McElligott, 2013). 
High triglycerides: ≤150 mg/dl or treatment for this lipid abnormality 
Hyperlipidemia: a metabolic condition causing high triglycerides and high 
cholesterol. 
Hyperglycemia: raised fasting glucose ≤ 100 mg/dl or diagnosed type 2 diabetes 





Hypertension: ≤ 140 mm Hg systolic or diastolic ≤ 90 mm Hg or treatment 
(Gionfriddo et al., 2014). 
Low high density lipoproteins (HDL): > 40 mg/dl in men and > 50 mg/dl in 
women or treatment. 
Metabolic syndrome: “A cluster of conditions—increased blood pressure, a high 
blood sugar level, excess body fat around the waist and abnormal cholesterol levels—that 
occur together, increasing your risk of heart disease, stroke, and diabetes” (Mayo Clinic, 
2014, para 1). These symptoms align with established biometric standards from the 
International Diabetes Federation and American Medical Association JNC8 (International 
Diabetes Federation, n.d.; Gionfriddo et al., 2014). 
Patient centered: An approach putting patients at the center of care, engaging 
their feedback, including them in decision-making, and ensuring they understand and are 
aligned with the treatment and care (Bertakis, Klea, 2011; Ganesh, 2009; Kraetschmer, 
Sharpe, Urowitz, & Deber, 2004; Tilburt et al., 2014). 
Patient engagement: A patient being actively engaged in his or her health care 
and having the knowledge and ability to perform health-promoting behaviors to manage 
health (AHRQ, 2011; Simmons et al., 2014).     
Assumptions, Limitations, and Delimitations 
Assumptions 
I assumed that NOVA Medical Group health care providers would participate in 





assumed that all patient data were uniformly collected and results were compared using 
industry-standard objective metrics.  
Limitations 
Limitations may influence outcomes due to the following: (a) nonrandomization 
of sampling frame, (b) patients having only MetS versus a more advanced chronic 
disease, (c) patients not returning for follow-up appointments within 4 months or seeing a 
provider from a different group, and (d) providers not applying integrative patient 
centered care training methods. A factorial purposeful sampling method was performed 
with MetS patients as defined above. Patient data were not randomly allotted to a control 
or research group but purposefully selected within the sampling frame. Because of the 
group development and intentional placement of patient data into one of two groups due 
to sampling frame constraints, randomized placement was not feasible.  
MetS patients were filtered out and selected based on the biometrics discussed 
above and/or their diagnosis of MetS. However, because only the above MetS symptoms 
were assessed, there may have been other symptoms or diagnoses related to chronic 
disease such as stroke or cancer that may not have been integrated into the assessment 
because they were not realized at time of selection. This could have influenced the health 
outcomes and the patient’s ability to engage in lifestyle changes and medication 
adherence.  
A third potential limitation was whether those selected for this study returned for 
follow-up appointments or whether they saw a different provider. In both groups, there 





follow-up appointments with the originally assigned provider, at which time more 
biometric data would have been collected. Because I de-identified all patients and was 
only assessing de-identified data, no patient consent was requested, and neither 
information nor incentives were given to motivate patient cooperation in this study. This 
may have reduced the amount of patient biometric data collected post provider training, 
thus potentially skewing results. In addition, there was the possibility that all biometrics 
received initially may not have been captured the next time based on providers’ clinical 
decisions and patient needs. If a lab biometric assessed initially was not indicated to be 
performed by the provider at the follow-up appointment, providers were under no 
obligation to have it performed and followed clinical practice guidelines. In addition, 
patients were aligned with their primary provider and divided into one of two research 
groups; it was possible they were not followed up by the original primary care provider 
and were seen by a provider from a different group, in which case their data would have 
been invalid. 
Integrative patient centered care training was provided to one of two group of 
providers; it offered ideas, methods, and approaches that were intended to advance the 
provider’s ability to engage with patients to promote healthy lifestyle behaviors, known 
as patient engagement. However, providers are different in how they learn and their 
ability to apply this training to their clinical patient visits. Also, the patient may not have 
had any desire to listen and apply suggestions on lifestyle and medication adherence 
regardless of how competently the provider engaged with them. These limitations on 





randomization of the sampling frame, and the possibility of patients not returning for 
follow-up appointments with their original provider, should be considered when 
assessing the results of the study. 
Delimitations 
Delimitations that frame this study included (a) applying a quantitative versus 
qualitative research methodology, (b) not conducting patient based surveys, (c) not 
researching chronic conditions as opposed to metabolic syndrome only, and (d) excluding 
those with conditions that may have impacted their biometrics or capacity to change 
lifestyle behavior and/or adhere to treatments such as those with severe psychological 
conditions.  
Methodology. A quantitative methodology was chosen based on time frame 
limitations, including not having the time necessary to receive patient consent and NOVA 
Medical Group’s preference for my research study. Keeping the time frame of this study 
to a practical 12 months warranted a quantitative rather than qualitative approach. There 
was not enough time to set up observational studies to include patient consent and 
integrating NOVA Medical Group’s provider-patient workflow into a qualitative study. 
Using a quantitative method and collecting biometrics and medication adherence data at 
timed intervals allowed for more efficient data collection. However, not having patient 
based information on the provider’s engagement approach and how they feel overall is a 
limitation in this study and should drive additional qualitative and quantitative studies. In 
addition, not being able to observe the providers with their patients prevented the ability 





reactions, and engagement that could drive provider training protocol development and 
be a factor in patient engagement. 
Patient surveys. Understanding how patients feel about their providers, their 
treatments, and their personal health goals is a component to understanding overall health 
outcomes. Health outcome measurements for this study were limited to biometrics. 
Measurements did not include how the patient feels, which may be a key indicator of 
health and quality of life improvement. If patient engagement is based on behavior 
modification and behaviors are affected by how someone feels, then this could be a 
significant factor that should be pursued in future research.  
Scope of patient population. Patient selection criteria were limited to those 
diagnosed with or meeting the standards for MetS. This was done to target a population 
that had the largest increased risk of developing a chronic condition, and intervening at a 
point most critical for initiating self-health promoting behaviors (i.e., patient 
engagement) to influence or reverse the potential disease trajectory. It was known that 
this population was at higher risk for chronic disease than those without MetS condition.   
Conditions impacting participation. Patients with other limiting conditions 
identified through established research methods such as electronic health record diagnosis 
were excluded. Limiting conditions may have significantly limited their ability to employ 
healthy patient engagement behaviors that may have impacted and potentially skewed 
biometric analysis outcomes (i.e., psychological impairments, disease diagnosis, physical 
or learning impairments). Such psychological conditions would include those that dictate 





included cancer that was being actively treated and congestive heart failure. If a disease 
was listed in the diagnosis section and there was a question of whether this might have 
significantly affected health outcomes and medication adherence, then I consulted with 
and receive guidance from lead medical providers, Dr. Grace Keenan or Dr. Chris 
Connolly, of NOVA Medical Group.  
Consent, Privacy, and Sampling Frame 
Health care providers were given a research identification number so they could 
be de-identified and correctly associated with their patient group (intervention or 
control). Patient information and provider information was de-identified and assigned 
into one of two research groups depending on location and quantity, and in accordance 
with internal review board criteria. No personal or private health information was 
associated with patients or providers in this study.  
Given the sampling frame of four NOVA Medical Group clinics, the population 
was selected from those with the following MetS criteria: hyperlipidemia (high 
triglycerides and high cholesterol) and hypertension. The intent was to enroll 500 
participants from the MetS population with approximately 50% in each group so that the 
sample size would be determined around the parameters of 2.5% margin of error, 90% 
confidence interval, and standard deviation of .5. 
A repeated measures MANOVA was performed and included assessing and 
comparing one independent variable with multiple dependent variables. Statistical 





Significance of the Study 
It was essential to understand what health care providers can do to motivate their 
patients to follow treatment plans and engage in their health behaviors. Learning and 
applying provider-patient engagement tools and skills may be a significant factor in 
improving patient health outcomes and medication adherence. Patient engagement and 
healthy behaviors are proven to have the highest impact on improving health outcomes 
and quality of life (Jacob & Serrano-Gil, 2010; Kones, 2013; Nield, 2008; Wolever et al., 
2011). These study outcomes are aligned with patient engagement behaviors that are 
potentially influenced by the relationship with their provider. How a provider engages 
with patients during the onsite patient appointment may prove to be a key factor in 
improving patient health outcomes and medication adherence. It may improve patient 
awareness, self-health promotion, and improved health. This may have a significant 
positive impact on patients’ quality of life, how they perform their day-to-day activities, 
and how they are able to meet their personal health goals (e.g., playing with grandkids, 
running a 5K, working all day without pain, etc.). When patients are educated and 
empowered to work with their health care providers and take ownership of their health, 
then a positive ripple effect occurs producing beneficial changes within themselves, their 
families, their employers/coworkers, their community, and beyond (Engel, 1977; 
Williams et al., 2000). 
This study was based on integrative patient centered provider training that may 
support results to drive understanding and application of integrative patient engagement 





additional patient engagement research to develop a patient engagement protocol and its 
potential applications. The study may provide processes and information for use in clinics 
that are already patient centered (e.g., accountable care organizations and patient centered 
medical homes). Additional benefits may include understanding what provider practices 
influence patient behavior and what aspects of provider care are important to the patient, 
all of which may have a direct impact on patients’ health-promoting behaviors and well-
being. 
There is a considerable amount of literature on MetS, patient engagement, and 
provider education; however, there is limited research on all three in the same study 
(Ampt et al., 2009; Brady et al., 2010; Burghen, 2005; Fifield et al., 2010; Graham, 2014; 
Jacobson & Gance-Cleveland, 2011; Karve & Hayward, 2010; Wiley et al., 2015; Xiang 
et al., 2014). This study may lead to improved patient medication adherence and 
improved health outcomes, and become a basis from which to approach and treat MetS 
and reinforce provider-patient engagement efforts. Knowing where to focus time, energy, 
and finances is critical, especially to health care providers and researchers. Understanding 
how to best support patient engagement and how to incorporate it into clinical practice 
workflow via training and best practices around MetS may prove to be an industry-wide, 
resource-saving, patient health promoting, and provider-friendly health care model 
(Barello et al., 2012; Bertakis & Azari, 2011; Institute of Medicine, 2001; Rittenhouse, 
Thom, & Schmittdiel, 2010; Simmons et al., 2014; U.S. Health Care Costs, 2012).    
This study had a critical mission to assess the effects of patient centered 





impacts patient engagement behaviors such that it influences medication adherence and 
health outcomes.  
Summary 
Patient engagement includes behaviors that impact lifestyle choices such as 
nutrition, exercise, stress management, restorative sleep, and pursuit of happiness. With 
appropriate lifestyle behavior changes, MetS and chronic diseases throughout the U.S. 
population may be significantly diminished. Primary care providers who develop patient 
centered engagement skills through furthering their training may be better equipped to 
influence patient engagement by using patient education and empowerment skills to 
inspire patients to take charge of their health and medicine. Health care training that 
provides conceptual and practical application of integrative patient centered care tools 
may support individual patient engagement health behaviors that in turn may positively 
impact MetS symptoms. This study has the potential to improve health outcomes, reduce 
chronic disease, decrease health care spending, and improve the overall life of those 
suffering with MetS.  
In Chapter 2, I present a literature review to provide an in-depth understanding of 
the theoretical foundation and biopsychosocial model used for this study. I describe 
strategies for searching the literature, the theoretical framework, and definitions and 
application of associated aspects of patient engagement, MetS, and medication 
adherence. It offers a comprehensive understanding of the basis for provider integrative 





results yielded gaps regarding consistent definitions of this term in the health care 






Chapter 2: Literature Review 
In this quantitative quasi-experimental study, I examined potential relationships 
between MetS patients’ health outcomes measured in biometrics (blood pressure, 
triglycerides, BMI, fasting blood glucose, hemoglobin A1c, high density lipoproteins) 
and medication adherence defined as taking or not taking (EHR noted or patient reported 
at clinical visit) and providers trained in patient centered engagement practices. This 
chapter includes literature search terms, the biopsychosocial theoretical framework, 
limitations of the biopsychosocial model in a primary care setting, patient engagement, 
MetS association with medication adherence, improved health outcomes, and provider 
education. 
Organization of the Review 
Significant studies were examined and integrated into the literature review. The 
first section presents strategies for searching the literature including search terms around 
the concepts of biopsychosocial, patient engagement, MetS, and provider education. The 
next section addresses the biopsychosocial theoretical framework, its evolution from 
general systems theory to the biopsychosocial construct in patient diagnosis and 
treatment, and its current application in this study. Views on the limitations of the 
biopsychosocial model with regards to its lack of comprehensiveness and the practical 
implications of limited time for use in daily clinical practice are given. Section three 
provides a definition and criteria for patient engagement in this study. Next an overview 
on MetS is presented, describing the link between MetS and chronic disease, the high 





impact patient engagement and improve health outcomes. Lastly, health outcomes and its 
correlation with medication adherence are discussed along with integrating provider 
training to improve both of these factors. The chapter concludes with a summary.  
Strategies for Searching the Literature 
I used Google Scholar, ProQuest, Sage, PubMed, Thoreau: Multiple Databases, 
Cochrane database, and books. The literature search focused around four main areas: (a) 
patient engagement and treatment, (b) MetS, (c) provider education (2009-2015), and (d) 
biopsychosocial models. Boolean operators were used to refine the search. Key search 
terms for patient engagement and treatment included patient engagement, personalized 
care, physician patient engagement, provider engagement, congruence, shared decision 
making, adherence, compliance, patient provider symmetry, participatory medicine, 
relationship centered care, patient empowerment, patient centered, collaboration, 
engagement, and self-management. Key search terms for metabolic syndrome included 
metabolic syndrome, chronic disease, metabolic syndrome symptoms, hyperlipidemia, 
hyperglycemic, pre-diabetes, body mass index, cholesterol, and obesity. Key search terms 
for provider education were filtered first by date range 2009-2015 to ensure most recent 
training protocols and research, and included the following: provider training, provider 
education, doctor education, doctor training, and provider behavior; all terms were 
searched with chronic disease and metabolic syndrome. The key search terms for 
researching biopsychosocial theory and constructs were biopsychosocial, mind/body 





comprehensive treatment, and patient centered. All terms were searched with chronic 
disease and metabolic syndrome. 
Theoretical Framework 
I used the biopsychosocial construct based on mind/body medicine in which the 
intrinsic capacities for disease prevention and healing are supported through integrating 
understanding of biology, psychology, and social influences into diagnosis and treatment 
(Bausell & Berman, 2002; Cox, 2011; Engel, 1977; Fremont & Bird, 1999; Freudenreich 
et al., 2010; Levin, 2009; Montori et al., 2013; Moss, c2003; von Bertalanffy, 1950; 
Williams et al., 2000). In his outline of general systems theory, von Bertalannffy (1950) 
described how within a living organism or any system, the whole is made up of 
interacting components that result in organized complexity, and that independent parts of 
the organism cannot be studied independently to understand the whole. This seminal 
work in systems theory laid the foundation for understanding and applying the 
biopsychosocial model in health care, diagnosis, and treatment.  
Biopsychosocial Model 
Engel (1977) described the impossibility of understanding illness without 
understanding the internal and external environment of the patient. This involved the 
provider engaging with patients to comprehensively assess the multiple facets that affect 
health. The approach included provider-patient centered engagement skills that take into 
account the patient’s biology, psychology, and social influences that can impact 
symptoms and disease (Engel, 1977; Freudenreich et al., 2010; Gorgens, 2006; Montori 





biopsychosocial training elements that provide education and support skill development 
with the intention of facilitating patient engagement behaviors to inspire or motivate the 
patient to improve self-care behaviors such that they positively influence medication 
adherence and health outcomes. 
Cox (2011) built on Engel’s biopsychosocial model and included the 
body/mind/spirit paradigm that supports the “emerging desire for greater multi-
professional collaboration…an integrative focus for those who recognized the conceptual 
limitations of a medical practice based on biomedicine alone” (p. 352). Cox also 
suggested integrating relationship-based medicine or patient centered care, “which 
incorporates meaning and purpose (spirit) as well as science and psychology” (p. 352). 
This contributed to the current understanding and application of the biopsychosocial 
model in which a provider assesses a patient’s biology, psychology, and sociocultural 
aspects to more comprehensively and effectively diagnosis and treat, which aligns with a 
patient centered approach to health care and delivery. 
Biopsychosocial Model Limitations 
Limitations noted here do not diminish the biopsychosocial model’s established 
efficacy in primary care and treatment, but they do address concerns in its comprehensive 
and effective application. First is the issue of not including basic elements into the patient 
centered inquiry, like ruling out neuropsychological conditions, becoming more precise 
in learning the patient’s biggest concerns, and realizing that what the patients want and 
why may be very different from what the provider understands and practices. Second, the 





approach takes time. It takes knowledge of information technology and electronic health 
record systems, knowledge of the classification codes to appropriately link counseling 
and treatment to codes that align with the biopsychosocial model and reimbursement, and 
knowledge of creative processes to integrate all of these components into practical 
workflows in a patient centered care setting. This requires time to train and most 
importantly time to work in a clinical setting with patients who usually have more than 
one health care issue to assess. This is not only a huge challenge in a fee-for-service 
model in which time is limited and the number of patients seen is maximized, but in most 
health care and delivery models in which time is often a factor and function of 
reimbursement and revenue.  
Adding to the biopsychosocial model. Freudenreich et al. (2010) discussed the 
application of the biopsychosocial model in clinical settings and its shortcomings and 
potential improved guidelines. Freudenreich et al., identified three guidelines for 
clinicians to use when inquiring: “1) Think neuroanatomically; 2) Think existentially; 
and 3) Think “dirty;” that is, understand that patients and physicians sometimes work 
toward different goals” (p. 365). This approach still includes the biopsychosocial model; 
however, providers are using portions of it more judiciously and adding components that 
had been overlooked by many who employed it (Freudenreich et al., 2010). The 
biopsycho portion points toward thinking neuroanatomically and finding out whether 
there is any common neurological condition present if cognitive, behavioral, or affective 
symptoms are noted. Basically providers want to rule out any biopsycho issue that could 





with this approach comes the added requirement for physicians to understand what to ask, 
how to interpret, and how to apply information received into diagnosis and treatment in a 
timely fashion. It is essential that training, workflow processes, proper coding, and time 
with patients integrate these additional components. 
Thinking existentially is recommended to ask questions that get to the core of 
what may be bothering the patient without all of the other social questions potentially 
asked on a patient centered intake. Freudenreich et al. (2010) suggested asking what the 
patient’s biggest fear is based on current life circumstances and that every physician 
should be able to help patients through “times of loss, fear and uncertainty” (p. 367). 
Even with this approach it is important not to get engulfed in the patient’s problems and 
suffering but to know enough to support the underlying needs and take time to ask 
questions, listen, and employ the most aligned and beneficial response and treatment. 
The final aspect covered by Freudenreich et al. (2010) is described as “think 
dirty,” the idea that patients may sometimes have ulterior motives for wanting certain 
treatments or care, not to suggest that patients are bad but to merely to state that a 
physician must be aware of possibilities not necessarily related to the physician’s 
presumed reasons for the medical appointment (p. 368). Freudenreich et al. noted that a 
doctor should not try to be everything to his or her patients and that the patient’s wants 
may not align ethically and/or along the lines of how a provider plans to treat; this 
ensures a provider’s training, skills, expertise and ethics are not overridden by a patient’s 
demands, regardless of potential patient backlash. 





providers is not having enough time with patients to adequately perform a comprehensive 
intake, listen to patients, and provide the counseling and care necessary, especially in a 
patient centered care setting (Klinkman & van Weel, 2011; Mauksch, 2005; Scherger, 
2005; Tilburt et al., 2014). The biopsychosocial model is complex and aligned with 
patient centered care in which providers take into account the whole patient including 
family, culture, social aspects, psychology, and biology (Freudenreich et al., 2010, 
Klinkman & van Weel, 2011; Mauksch, 2005; Scherger, 2005). Having enough time to 
apply and practice the biopsychosocial model of care presents challenges in 
understanding the model, incorporating the practice into clinical workflow, and being 
reimbursed for these patient centered practices. 
Patient Engagement Factors  
Patient engagement is described as self-health promoting behaviors that influence 
health outcomes. This health behavior dynamic was the basis for the study. Determining 
what factors impact patient engagement is important. Research was conducted to 
determine whether provider patient centered training was a factor in patient engagement, 
and whether it is necessary to understand one of many potential factors that may impact 
why and how a patient engages in his or her health care. In the health care industry, there 
is limited consensus around the term patient engagement, so this literature search was 
performed to determine the best definition supported by research and aligned with the 
constructs of this study (Barello et al., 2012; Bertakis & Azari, 2011; DiMatteo et al., 
1992; Dunbar-Jacob & Mortimer-Stephens, 2001; Institute of Medicine, 2001). In 





biometric values in order to have established standards to ensure reliable metrics and 
analytical comparisons. Provider education, this study’s independent variable, was 
searched to have a fuller understanding of the potentially positive impact on patient 
engagement and health outcomes. 
Patient Engagement Defined 
I used two areas of literature for my patient engagement definition in this study. 
First, patient engagement is defined by the Agency for Healthcare Quality and Research 
(AHQR, 2011) as “an ongoing process in which patients take an active role in their own 
healthcare” and involve factors including “personal skills, motivation, and behaviors-
affect an individual’s ability to effectively engage in care” (p. 1). Second, Simmons et al. 
(2014) used this definition in their systematic review of clinical trials on patient 
engagement. Simmons et al. evaluated 543 abstracts, and only 10 trials met their criteria 
that defined patient engagement as (a) understanding the importance of taking an active 
role in one’s health and health care; (b) having the knowledge, skills, and confidence to 
manage health; and (c) using knowledge, skills, and confidence to perform health-
promoting behaviors.  
Patient Engagement Improvement and Improved Health Outcomes  
Out of the 10 trials mentioned above, four were used to measure knowledge, 
confidence, and skills of patient engagement (Hibbard, Mahoney, Stock, & Tusler, 2007; 
Lorig et al., 2010; Lorig, Ritter, Villa, & Armas, 2009; Wolever et al., 2010). Five (50%) 
used chronic disease metrics like the ones used in this study (Barlow, Edwards, & Turner, 





Huang, Li, & Wang, 2009; Lavery, O’Neill, Parker, Elborn, & Bradley, 2011). One trial 
used a self-efficacy measure (Moriyama et al., 2009). In addition these studies had 
behavioral measures, with one measure being medication adherence, which aligns with a 
measure that was assessed in this study (Glasgow et al., 2012). Nine out 10  (90%) 
reported improved patient engagement (Glasgow et al., 2012; Goeppinger, Armstrong, 
Schwartz, Ensley, Brady, 2007; Hibbard et al., 2007; Huang et al., 2009; Lavery, O’Neill, 
Parker, Elborn, & Bradley, 2011; Lorig et al., 2010; Lorig, Ritter, Villa, & Armas, 2009; 
Moriyama et al., 2009; Wolever et al., 2010).  
Aligned with patient engagement improvement there were five studies or 50% 
that showed clinical biological outcome improvements (Glasgow et al., 2012; Lorig et al., 
2010; Lorig et al., 2009; Moriyama et al., 2009; Wolever et al., 2010). Specifically 
HbA1c, lipids, blood pressure were the same biological indicators this study assessed. 
This research, which examined 543 abstracts on patient engagement, narrowed them 
down to 10 trials that had three components that were used to frame and support their 
research (a) understanding the importance of taking an active role in one’s health and 
health care; (b) having the knowledge, skills, and confidence to manage health; and (c) 
using knowledge, skills and confidence to perform health-promoting behaviors (Simmons 
et al., 2014, p. 3). The study supported the correlation between patient engagement and 
improved health outcomes and stated, “the role of patient engagement in chronic disease 
care is increasingly being cited as critical for improving health outcomes and reducing 
costs” (Simmons et al., 2014, p. 12). These 10 trials had the above three components 





protocol. In addition it was the foundational study for directing further research that 
reported the link between patient engagement and improved health outcomes. The term 
patient engagement for this research was established based on Simmons et al. (2014) 
three criteria that also aligned with AHRQ’s standard definition. This provided a reliable 
and valid foundation for use, application and development of this patient engagement 
concept. 
Metabolic Syndrome Delineated 
Metabolic syndrome describes a person with three or more symptoms or 
precursors to chronic diseases ( cardiovascular disease, type 2 diabetes, and stroke) (Crist 
et al., 2012; Dickerson et al., 2011; International Diabetes Federation, n.d.; Ma & Zhu, 
2013). The symptoms include, high body mass index, high waist circumference, 
hyperglycemia, low cholesterol high-density lipoprotein (HDL), and high triglycerides 
(Crist et al., 2012; Burghen, 2005; International Diabetes Federation, n.d.; Ma & Zhu, 
2013). Diminishing the rate of MetS can reduce chronic disease such as cardiovascular 
and diabetes type II which costs the U.S. over 75% of our nation’s 2 trillion spent on 
healthcare (CDC, 2011).  
Association Between MetS and Chronic Disease 
The association between MetS and chronic disease has been established by 
multiple studies. A 2010 study analyzed GE Centricity electronic medical record (EMR) 
data that captured patient level clinical data from clinical data services (CDS) that used 
over 133 provider groups containing 7259 physicians at 98 installations and 8.9 million 





potential relationships between “obesity and 3 key chronic disease states: type II diabetes, 
hyperlipidemia, and hypertension. The positive association between obesity and the 3 
comorbid conditions in the GE Centricity database is similar to that found for US 
populations” (Crawford et al., 2010, p.157). A more recent study indicated a significant 
relationship between symptomatic carotid disease and metabolic syndrome, 
demonstrating MetS indicators such as high triglycerides, obesity, and high glucose 
levels are associated with cardiovascular disease (Maksimovic, Vlajinac, Radak, 
Marinkovic, & Jorga, 2012).  
According to the National Health and Nutrition Examination Survey (NHANES) 
statistics 2002-2006 report, approximately 34% of adults over 20 years old meet the 
criteria for metabolic syndrome and that MetS increased with age and body mass index 
(Ervin, 2009). The 40-59 years old of males and females showed a three times higher 
incidence of meeting MetS criteria than 20-39 year olds. Males over 60 years were four 
times more likely and females over 60 years were six times more likely over the younger 
group to meet MetS criteria (Ervin, 2009). A more recent study used the NHANES 1999 
to 2010 surveys in two year waves; these indicated that within the U.S. population 
approximately one-fifth of adults had a cardiometabolic risk (Beltrán-Sánchez et al., 
2013). These statistics indicated 34% of adults in the U.S. have metabolic syndrome and 
one fifth of these adults specifically had cardiometabolic risk (Beltrán-Sánchez et al., 
2013; Ervin, 2009). These large study statistics indicated a clear and present need to 
understand how to diminish MetS to prevent the onset of chronic disease, mortality, 






Diet and Exercise Behaviors Influence MetS 
As discussed there was an abundance of research on metabolic syndrome, 
however gaps were found in best practices and ways to prevent these symptoms (Appel, 
Jones, & Kennedy-Malone, 2004; Burghen, 2005; Dickerson et al., 2011; Ma & Zhu, 
2013). A Cochrane study reviewed the effects of exercise and diet, or exercise only on 
people at high risk for type 2 diabetes, an indicator of MetS. The study included eight 
trials with 2,241 participants in the exercise plus diet group and 2,509 participants in the 
standard recommendation group (Orozco, 2008). Orozco concluded that diet with 
exercise had a significant effect on those in high risk groups described as those with 
MetS or impaired glucose tolerance (Orozco, 2008). This meta-analysis was limited in 
understanding the “effects of exercise and diet on quality of life, morbidity and mortality, 
with special focus on cardiovascular outcomes” (Orozco, 2008, p.5). However the study 
used biometric outcomes to measure MetS indicators, and the relationship of diet and 
exercise behaviors on biometrics associated with MetS.  
If providers know methods to motivate patient engagement then positive lifestyle 
behaviors, (e.g., diet and exercise) may be facilitated. Some providers may not have 
received training in how best to motivate patients and encourage positive life style 
behaviors, however training is available now. Research depicts the link between provider 
training and influence on patient behavior thereby health outcomes, so it is plausible 
based on the literature that MetS patient engagement behaviors may be impacted by 





Burghen, 2005; Fifield et al., 2010; Graham, 2014; Jacobson & Gance-Cleveland, 2011; 
Karve & Hayward, 2010; Wiley et al., 2015; Xiang, Wethington, Onufrak, & Belay, 
2014).  
Another aspect of MetS review was to determine what biometrics were the best 
indicators of this condition and most commonly collected. These biometrics were: blood 
pressure, triglycerides, BMI, fasting blood glucose, and/or high density lipoproteins 
(Burghen, 2005; International Diabetes Federation, n.d.; Ma & Zhu, 2013). 
Medication Adherence, Improved Health Outcomes, and Provider Education  
Medication adherence and improved health outcomes. Medication adherence 
is a major contributing factor in improving health outcomes. The World Health 
Organization (WHO) stated those with chronic conditions have a 50% treatment non-
adherence rate (World Health Organization, 2003). The consequences “include 
worsening condition, increased comorbid disease, increased health care costs, and death” 
(Chisholm-Burns & Spivey, 2012, p. 826). There are different reasons for medication 
nonadherence however a shared approach of collaboration and communication between 
healthcare providers and their patients with aims for a common goal of improved health 
outcomes may be key (Brunton, 2011; Chisholm-Burns & Spivey, 2012; Khanna et al., 
2012; McHorney & Spain, 2011).  
A 2014 study using 649,904 patients diagnosed (based on International 
Classification of Disease 10 codes) with hypertension, 199,312 diagnosed with diabetes 
and 290,543 diagnosed with hyperlipidemia indicated there were higher hospitalizations 





diabetes (Han, Suh, Lee, & Jang, 2014). In addition to hospital related medicine 
nonadherence costs, a study by Khanna, et al., (2012) stated 4 billion prescriptions in the 
United States were dispensed contributing to 10% of the overall 2.5 trillion in health care 
costs with approximately half of the medication not taken as prescribed. More important 
than the financial health care costs are the deaths associated with poor adherence 
estimated at 125,000 individuals per year, in addition to the adverse effects associated 
with morbidity (Khanna et al., 2012; Makarem, Smith, Mudambi, & Hunt, 2014). The 
financial, physical, and emotional ramifications of nonadherence is highlighted by the 
statistic that half of those who fill a prescription do not continue the medicines after six 
months (Brunton, 2011; McHorney & Spain, 2011). Medication adherence directly 
correlates with health outcomes and is a significant challenge. Supporting this component 
of patient care through provider education and improved patient engagement may 
positively contribute to improved overall health outcomes. 
Provider education. In my research provider education and training will be given 
in order to promote health care providers’ ability to facilitate patient self-healthy 
behaviors (patient engagement) such as better nutrition, exercise, stress management, 
restorative sleep, pursuit of happiness and medication adherence (AHRQ, 2011; Brunton, 
2011; Chisholm-Burns & Spivey, 2012; Cox, 2011; Engel, 1977; Guarneri & Tager, 
2014; Khanna et al., 2012; Simmons et al., 2014; Williams et al., 2000). I will educate on 
the understanding and application of biopsychosocial and patient centered care practices 
that include family, culture and social aspects. This training will aim to promote patient 





Monitoring patient reported medication adherence is one way to determine if 
patients are taking what is being prescribed. Improving medication adherence is a factor 
in reducing morbidity and mortality (Brunton, 2011; Chisholm-Burns & Spivey, 2012; 
Khanna et al., 2012; McHorney & Spain, 2011). Giving health care providers the tools 
and training to improve patient engagement and thereby medication adherence is a key 
factor in determining if training has an influence on patients taking prescriptions. Various 
ways to improve medication adherence through patient provider relations and 
communications on supporting health promoting behaviors have been researched (Bosch-
Capblanch, 2009; Brunton, 2011; Makarem et al., 2014; Street Jr., 2013; Viswanathan et 
al., 2012).  
This research protocol includes provider patient engagement training and will 
incorporate a cross-section of researched methods to include promoting cognitive and 
emotional reasons (utilizing the biopsychosocial patient centered model) for taking 
prescribed treatments, creating goals that are patient centered, and understanding and 
integrating health literacy based on demographics and other patient intake information 
(Bertakis, Klea, 2011; Bosch-Capblanch, 2009; Brunton, 2011; Makarem et al., 2014; 
McHorney & Spain, 2011Street Jr., 2013; Rittenhouse et al.,, 2010; Viswanathan et al., 
2012; World Health Organization, 2003). 
Literature searches revealed large amounts of research on MetS, patient 
engagement, and provider education independently; however information is limited when 
reviewed together or in different combinations (Ampt et al., 2009; Brady, Solomon, Neu, 





Gance-Cleveland, 2011; Karve & Hayward, 2010; Wiley et al., 2015; Xiang, Wethington, 
Onufrak, & Belay, 2014). This gap in research on provider education and its potential 
impact on patient engagement with metabolic syndrome patients drove my proposed 
research study. Educational programs that advance provider patient engagement skills 
and how to incorporate these into daily clinical practice may be a wise fiscal and 
fundamental initiative (Barello et al., 2012; Bertakis & Azari, 2011; Institute of 
Medicine, 2001; Rittenhouse et al., 2010; Simmons et al., 2014; Kaiser, 2012).  
Summary 
This literature review listed all significant search terms, the biopsychosocial 
theoretical framework, and defined patient engagement. Patient engagement factors 
described included metabolic syndrome, link between MetS and chronic disease, and the 
large U.S. population affected. I highlighted the lack of research on provider training and 
the potential impact this could have on patient engagement and medication adherence. 
Major studies were examined to understand the immense amount of research performed 
on patient engagement, in addition to the deficiency of research around my proposed 
study of provider training to improve patient engagement behaviors. The following 
chapter is an explanation of research methods used to analyze the effects of provider 






Chapter 3: Research Methods 
In this quasi-experimental study, I examined the potential effects of the 
independent variable, integrative patient centered provider training, on the dependent 
variables of health outcomes (biometrics) and medication adherence (EHR noted and 
physician reviewed at clinical visit) of patients with metabolic syndrome. There is little 
research addressing the correlation between provider training, patient engagement, and 
health outcomes. Due to this gap, there was a need for further study. Follow-on studies 
may enhance generalizability of findings. 
This chapter presents the method and design and is organized into five sections. 
The first section includes the reasoning for using a quantitative quasi-experimental design 
and the research questions. The next section details the sampling and sampling 
procedures, including the sampling frame and size. In the third section I identify the 
dependent variables of health outcomes (disease biometrics) and medication adherence 
(EHR noted) and the independent variable data (two provider groups). In the fourth 
section, I describe the ethical considerations and how patient data was de-identified, 
collected, and protected, as well as how ethical procedures were employed with the 
provider groups to ensure understanding and agreement. The fifth section presents the 
instrumentation and materials used. A summary concludes this chapter.  The Institutional 
Review Board (IRB) approval number for this research is 08-14-15-0330260. 
Research Design and Approach 
I employed a quantitative quasi-experimental design. The purpose was to 





provider training) on the dependent variables of health outcomes (biometrics) and 
medication adherence (EHR noted) of patients with MetS. The metrics aligned with 
established biometric standards from the International Diabetes Federation and American 
Medical Association JNC8 (Gionfriddo et al., 2014; International Diabetes Federation, 
n.d.). The biometrics included the following: (a) hyperlipidemia, metabolic condition 
causing high triglycerides and high cholesterol; (b) high triglycerides, ≤150 mg/dl or 
treatment for this lipid abnormality; (c) low high density lipoproteins (HDL),  > 40 mg/dl 
in men and > 50 mg/dl in women or treatment; (d) hyperglycemia, a raised fasting 
glucose ≤100 mg/dl or diagnosed type 2 diabetes (International Diabetes Federation, 
n.d.); (e) hypertension, ≤ 140 mm Hg systolic or diastolic ≤ 90 mm Hg or treatment 
(Gionfriddo et al., 2014); and high body mass index (BMI) defined as ≤ 30 kg/m2 and 
correlated with increased MetS and age (Beltrán-Sánchez et al., 2013).  
I compared the efficacy of a patient engagement protocol on medication 
adherence and health outcomes between two groups: (a) integrative patient centered  
provider training for providers (intervention group), and (b) no integrative patient 
centered training for providers (control group). The intent of the intervention groups was 
to determine the effects of newly administered integrative patient centered provider 
training on patients with MetS. This comparative effectiveness research analyzed and 
compared the effects of integrative patient centered care training on medication 





Research Questions and Hypotheses  
RQ1: Is there a difference in disease biometrics outcomes (blood pressure, 
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins) 
in patients with MetS following implementation of a patient engagement provider 
training protocol in an integrative health clinic? 
H1n: There is no difference in disease biometrics outcomes (blood pressure, 
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins) 
in patients with MetS following implementation of a patient engagement provider 
training protocol in an integrative health clinic. 
H1a: There is a difference in disease biometrics outcomes (blood pressure, 
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins) 
in patients with MetS following implementation of a patient engagement provider 
training protocol in an integrative health clinic. 
RQ2: Is there a difference in medication adherence (EHR noted or patient 
reported at clinical visit) in patients with MetS following implementation of a patient 
engagement provider training protocol in an integrative health clinic? 
H2n: There is no difference in medication adherence (EHR noted or patient 
reported at clinical visit) in patients with MetS following implementation of a patient 
engagement provider training protocol in an integrative health clinic. 
H2a: There is a difference in medication adherence (EHR noted or patient 
reported at clinical visit) in patients with MetS following implementation of a patient 





Health outcomes and medication adherence were the dependent variables, and 
patient engagement patient centered provider training was the independent variable.  
Sampling and Missing Data 
Sampling Selection  
I used a purposeful sampling protocol based on patients’ MetS data. The nature of 
the sampling frame (such that limited number of patients met the study’s inclusion 
criteria of having six MetS indicators) from NOVA Medical Group clinics, patient 
randomization was infeasible however provider randomization was feasible. From eight 
to 10 providers, four to five were used for Group 1 (integrative patient centered care 
training), and four to five were used for Group 2 (integrative patient centered care 
training). My sample was obtained through performing two series of patient data filtering. 
The initial patient data filtering was based on those who had the following study MetS 
indicators: hyperlipidemia (high triglycerides, high cholesterol) and hypertension. These 
indicators were selected because they yielded the highest number of patients and 
produced 515 patient data. A second filtering was performed on this initial set and used 
the remaining research MetS indicators (HbA1c, fasting glucose, BMI) and produced 91 
patient data, which was my applied research sample size. Because patient randomization 
was not feasible, internal validity was strengthened by random division of providers who 
had MetS patients; they were placed into two study groups (intervention or control) based 
on creating comparable patient sample sizes for each provider group (Frankfort-






The patient data under study met the inclusion criteria of having the MetS 
symptoms described above. Exclusion criteria included people less than 18 years of age 
and those with conditions that may have impacted their ability to successfully employ 
patient engagement behaviors (e.g., psychological or cognitive limiting conditions noted 
on EHR). Patient information and data and provider information were de-identified and 
assigned into one of two research groups depending on location and in accordance with 
internal review board criteria.  
The sampling frame was derived from four NOVA Medical Group clinics, and the 
population was filtered by those having three of the six MetS indicators: hyperlipidemia 
(high triglycerides and high cholesterol) and hypertension, and then on the remaining 
three MetS indicators (HbA1c, fasting glucose, BMI) yielding 91 patient data. 
Based on this sample size of 91 MetS patients the specified margin of error of 
10.0% with a 80% power at 95% confidence level and a standard deviation of .5 with a 
medium effect. With a confidence level at 95%, this corresponded to a z score of 1.96. To 
find the sample size needed, I used the following formula. Necessary sample size = (Z 
score)2 *StdDev* (1 StdDev) / (margin of error)2 = (1.96)2 x .5(.5) / (.10)2 = (3.84 x .25) / 
.01 = .96 / .01 = 96. 
With attrition estimated at 30%, the minimum required sample was (96 + 96*0.3 ~ =) 125 






Missing data could have occurred for multiple reasons. First, providers may have 
opted out of the training at any point during the study. Another trained provider could 
have taken over the patient cases if that provider met the group criteria (i.e., received or 
had not received the intervention training). These potential scenarios should not have 
affected the study sample size because sample size was based on patient numbers, not 
number of providers. As long as the providers working with the assigned population had 
or had not received the integrative patient centered care training, respectively, then all 
other factors remained constant. 
 Another potential for missing data was having a provider from one research 
group following-up with patients originally seen by the other group. Other challenges 
included, patients that did not return for follow-up appointments within the four month 
post intervention time frame, and research biometric labs not requested by the provider 
and/or not performed by the patient.  
Overall, 37 patients were assigned to provider Group 1 (intervention) and 54 
patient to provider Group 2 (control). It was not possible to obtain data from additional 
patients to meet the minimum required sample size of 125. 
Assumptions 
The assumptions for multivariate analysis of variance (MANOVA) were the 
following: 
1. Dependent variables are continuous variables measured at the 





2. The Independent variable clearly divides the study participants into two 
independent groups (integrative patient centered care training, and one 
group not given integrative patient centered care training). 
3. Each study participant in a group was selected independent of other study 
participant in the same group.  
4. Each group has enough cases based on the minimum required sample size, 
and the groups are balanced.  
5. There are no extreme values (outliers) in the dependent variable and in 
each of the covariates. In the current study, MetS biomedical parameters 
had large variances due to their probable large deviations from normal 
(non MetS) patients. 
6. The dependent variable and each of the covariates measured on continuous 
scale follow normal distribution.  
7. There is linear relationships between dependent variable and each of the 
continuous independent variables.  
8. There is homogeneity of variance such that there are similar variances in 
each of the groups. The assumption was assessed using Pillai’s criteria and 
Box’s M test of equality of covariance. The assumption of homogeneity of 
variance-covariance was not met, and the null hypotheses was rejected.  
9. There should be no multicollinearity between continuous independent 





Dependent and Independent Variables: 
There are seven dependent variables in this study. The biomedical variables 
include: blood pressure, triglycerides, body mass index (BMI), fasting blood glucose, 
hemoglobin A1c, and high density lipoproteins. The medication adherence variable is 
defined as “taking” or “not taking” medication (noted on EHR). The 
independent/intervention variable is provider education on integrative patient centered 
care, received or not received.  
Dependent: Health Outcomes and Medication Adherence  
The effects of patient engagement factors on medication adherence (EHR noted) 
and disease management outcomes biometrics (e.g., blood pressure, triglycerides, body 
mass index (BMI), blood glucose serum, HbA1c, and high density lipoproteins) were 
compared between two patient groups within a health care clinical system. 
Independent Variable: Provider Education 
Two provider groups were established with respects to the independent variable. 
The groups were comprised of providers who received integrative patient centered  
training (intervention), and those providers who did not receive integrative patient 
centered training (control). The intent of the intervention group was to determine the 
effects of newly administered integrative patient centered provider training on patients 
with MetS. This comparative effectiveness research analyzed and compared the potential 
different effects from integrative patient centered training between provider groups. It 
analyzed and compared the effects of integrative patient centered training on disease 





relationships. These outcomes of integrative patient centered engagement training can be 
compared to other patient engagement efforts to determine levels of effectiveness based 
on medication adherence and disease management outcomes. 
Provider training was developed based on patient centered health care methods 
shown to improve patient satisfaction and health outcomes. These methods are based on 
patient centered medical home (PCMH) tenets; accountable care organization criteria; the 
health belief model; and current research integrating components of building healing 
relationships, motivational interviewing, and the seek, help, assess, reach, evaluate 
(SHARE) approach (AHRQ, 2012; Bertakis, Klea, 2011; Guarneri & Tager, 2014; 
Institute of Medicine, 2001; Rittenhouse et al., 2010; Tilburt et al., 2014; Wolever et al., 
2011). There were approximately 65 health care providers in this study to include 
medical doctors, nurse practitioners, doctors of naturopathic medicine, nutritionists, and 
nurses; with anticipated 90% participation rate from the practitioners and nurses. The 
training was a total of six hours divided up into approximately two hour blocks one day a 
week for three consecutive weeks. I provided the training using audio-visual equipment, 
PowerPoint presentations, participant role-play, humor, and team engagement. See 
appendix A. 
Data Analysis Plan 
Repeated measures MANOVA was utilized to examine how each patient’s data 
compared across the two capture periods. Baseline (pre intervention) patient data was 
collected from the EHR at the start of active research (post IRB approval). This pre 





data on patient EHR. Post intervention data (after provider training was given) was 
collected after the patient’s follow-up clinical visit, approximately three to four months 
after the last training class. Repeated measures MANOVA were performed and included 
assessing and comparing one independent variable with multiple dependent variables. 
SPSS statistical program was used for the analysis. 
Research Questions  
RQ1: Is there a difference in disease biometrics outcomes (blood pressure, 
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins) 
in patients with MetS following implementation of a patient engagement provider 
training protocol in an integrative health clinic? 
Below is the example table for delineating the collected biometric data. 
Table 1  
Example Biometrics Data Collected 
Variable Baseline Mean  
± Standard Deviation 
Post Intervention Baseline Mean  
± Standard Deviation 
Provider Training Group    
BMI Kg/m2   
 
HbA1c %  
 
Fasting Glucose mg/dl   
 
Triglycerides mg/dl    
 
Systolic BP mmHg    
 
Diastolic BP mmHg   
 







RQ2: Is there a difference in medication adherence (EHR noted or patient 
reported at clinical visit) in patients with Metabolic Syndrome following implementation 
of a patient engagement provider training protocol in a health clinic? 
Below is the example table for delineating the collected medication adherence 
data. 
Table 2 
Example Medication Adherence Data Collected  











Patient data de-identified, collected and protected 
Patients’ data were de-identified by removing all identifying information and 
replaced with an identification research number. Only the primary investigator and 
designated NOVA Medical Group (NMG) staff had access to this information. Because 





with the data, thus no HIPAA or privacy act violations were probable; therefore consent 
from patients to use this data was not necessary (this determination was approved by the 
IRB). The data were kept in password protected electronic files and all methods and 
procedures around data complied with IRB, HIPAA, Privacy Act, and NMG regulating 
criteria. 
Provider Group Consent 
All providers were divided into one of two groups. Those provided the training 
were given a description of the research and their participator role. Provider 
demographics were collected to include age, years of practice, degree, and medical 
school attended, though these details were not integrated into study analysis. All 
providers were de-identified and given a provider group number (1 or 2) and randomly 
assigned to the intervention or control group. 
Instrumentation and Materials  
Biometrics scales and standards were based on industry standards as indicated 
previously. SPSS software was used to establish analytical testing programs, produce 
tables and drive interpretation of outcomes.  
Summary 
In summary this chapter discussed the details and development of my quantitative 
quasi-experimental study. It showed what research methods and procedures were 
employed to determine potential effects of the independent variable (integrative patient 
centered training) on dependent variables (health outcomes) and medication adherence 





Chapter 4: Results 
This chapter presents findings of the integrative patient centered engagement 
training study including patient data, demographics, descriptive statistics, data capture 
challenges, data compilation, and data analysis. The previous three chapters introduced 
and described the need for this study, provided an in-depth literature review, and research 
methods were explained. In Chapter 4, I describe the use of repeated measures 
MANOVA to test for significant differences between provider groups who had the 
intervention (integrative patient centered training) and those who did not have the 
training. In addition, I describe the analysis done across time to determine whether there 
were significant differences between health outcomes. A summary of findings concludes 
the chapter.  
Research Data 
Patient Data Numbers 
Initial baseline patient data were collected within 12 months of intervention start 
date (integrative patient centered training). Metabolic syndrome patient selection criteria 
were based on a diagnosis of MetS and having baseline data on triglycerides, blood 
glucose, HbA1c, HDL cholesterol, body mass index, blood pressure, and medication 
adherence. After clinical chart review for complete post intervention data, the initial 
sample size decreased from 91 total patient data, with 37 from Group 1 (provider training 
intervention group) and 54 from Group 2 (control group who did not receive the 
training), to 43 total patient data with 13 from Group 1 and 30 from Group 2. Due to the 





baseline values cared forward. Analysis was performed on both the ITT group using the 
original 91 patient data, and on the completer data set using 43 total patient data. These 
two data sets will be described later in the chapter. 
Patient Demographics 
Age ranged from 31 years to 90 years, with the 46-60 range at 49.5% of 
participants and 61-75 range at 37.4% of participants. Participants included 61.5% 
females and 38.5% males. Demographic data are presented in Table 3 and Table 4. 
Table 3 
Age Range Data Set Comparing Provider Training Group (Intervention) and Non-
Provider Training Group (Control) 
 
 














3 19 13 2 37 
Control Group Non-
Provider Training 
2 26 21 5 54 
Total (n) 5 45 34 7 91 
 
Table 4 
Female and Male Participants 









Descriptive Statistics and Sample Size 
The total original sample was 91 with 37 patient data in the provider training 
group and 54 patient data in the non-training group. Within this initial group of 91, data 
were missing as indicated by lower numbers next to the biometric collected (see Table 5). 
Data were analyzed using mean and standard deviation at two points in time, baseline and 
post intervention measurement 3 to 4 months after intervention (provider training). 







Descriptive Statistics for Research Population  
 Baseline 
Mean ± SD Values 
 
Provider Training Group: 
Intervention 
 
BMI Kg/m2 n = 37  
 
HbA1c %  n = 36  
 
Fasting Glucose mg/dl  n = 36  
 
Triglycerides mg/dl n = 35  
 
Systolic BP mmHg  n = 37  
 
Diastolic BP mmHg  n = 37  
 




32.92 ± 7.29 
 
5.98 ± .40 
 
99.36 ± 11.81 
 
146.03 ± 81.13 
 
127.43 ± 14.89 
 
79.46 ± 12.77 
 
56.16 ± 18.28 
 
Non-Provider Training Group: 
Control 
 
BMI Kg/m2 n = 54 
 
HbA1c %  n = 48  
 
Fasting Glucose mg/dl  n = 53  
 
Triglycerides mg/dl  n = 48  
 
Systolic BP mmHg  n = 53 
  
Diastolic BP mmHg n = 53 
 





31.51 ± 7.86 
 
5.99 ± .93 
 
102.00 ± 37.96 
 
148.40 ± 65.48 
 
132.26 ± 16.71 
 
82.59 ± 12.85 
 





Data Compilation and Table 
Research Question 1 was applied to both the completer data set (43 total patient 
data) and the ITT data set (91 total patient data). The ITT data set used values carried 
forward from baseline if the post intervention data was missing or had to be removed 
because it invalidated the integrity of provider group. Research Question 2 could not be 
answered due to discrepancy of outcomes; data did not achieve criterion validity 
standards and construct validity was not met. The definition of medication adherence was 
not consistently followed across patient EHRs, thus not reliable. If incorporated, results 
would have been skewed and/or completely inaccurate. This finding is discussed in 
Chapter 5. 
Research Questions and Hypothesis            
Research Question 1 assessed if there was a difference in disease biometrics 
outcomes (blood pressure (systolic and diastolic), triglycerides, body mass index (BMI), 
blood glucose (HbA1c and serum), and high density lipoproteins) in patients with 
Metabolic syndrome following implementation of a patient engagement provider training 
protocol in an integrative health clinic. The null and alternative hypotheses described if 
there was or was not a difference in disease biometrics outcomes following implantation 
of the patient engagement protocol. 
 
Data Compilation and Completer Data Set 
The completer data set had a total of 13 patient data from the provider training 





small sample size could increase the likelihood of type II errors and a failure to reject a 
false null hypothesis (Creswell, 2009; Frankfort-Nachmias & Nachmias, 2008). Mean 
and standard deviation values were analyzed at two points in time, the baseline and at 
three to four months post intervention. Within the completer data set, statistically 
significantly (p < 0.05) values across time included a decrease in BMI within the provider 
training Group 1 (from 35.14 ± 7.9 Kg/m2  to 33.65* ±  7.62 Kg/m2; p value for 
difference < 0.05; Table 6); but not within the non-training Group 2 (32.4 ± 6.62 Kg/m2 
to 32.4 ± 6.5 Kg/m2; p value for difference  > 0.05; Table 6). There was an increase in 
fasting glucose levels in both provider groups: training Group 1 (from 99.00 ± 12.84 
mg/dl to 104.46* ± 20.12 mg/dl; p value for difference < 0.05; Table 6) and non-training 
Group 2 (from 101.33 ± 13.40 mg/dl  to 105.47* ± 18.60 mg/dl; p value for difference  
< 0.05; Table 6). However, there was no statistically significant difference in BMI 


























Completer Data of Biometric Data Between Provider Groups 
 
 
Note. * Significant from baseline at p < 0.05  
 Baseline 




Mean + SD Values 
 
 
F Statistic  




Fasting Glucose  mg/dl 
Triglycerides mg/dl 
Systolic BP mmHg 
Diastolic BP mmHg 
HDL Cholesterol mg/dl 
 
 
35.14 ± 7.87 
6.07 ± .45 
99.00 ± 12.84 
164.15 ± 110.77 
129.46 ± 21.87 
81.08 ± 18.81 
51.54 ± 19.97 
 
 
33.65* ±  7.62 
5.92 ±  .34 
104.46 *± 20.12 
151.00 ± 84.54 
128.92 ± 21.18 
79.44 ± 18.71 










Non Training Group  
n=30 
BMI Kg/m2 
HbA1c   % 
Fasting Glucose mg/dl 
Triglycerides mg/dl 
Systolic BP  mmHg 




32.42 ± 6.96 
5.91 ± .42 
101.33 ± 13.40 
150.70 ± 70.57 
136.80 ± 16.88 
81.42 ± 11.04 
53.70 ± 18.80 
 
 
32.13 ± 6.53 
5.83 ± .45 
105.47* ± 18.60 
154.37 ± 66.30 
130.77 ± 15.60 
82.47 ± 11.90 
















Repeated measures MANOVA was performed with the completer data set. 
Provider training group (intervention) and non-training (control) as the between subject 
variables and time as the within subject variable, with two time points (pre and post 
intervention).  
Time has a statistically significant effect on fasting glucose level, such that fasting 
glucose level significantly (F (1, 4) = 4.28, p < 0.05) increased over time. In addition, a 
statistically significant (F (1, 4) = 3.86, p < 0.05) effect was found between follow-up 
times and BMI for the training group (but not for the non-training group). Therefore, time 
had a statistically significant effect on BMI in the training group alone, but as stated 
previously there was no statistically significant difference between the provider training 
groups. Because significance was only noted between time frames and not between 
provider groups for both fasting glucose and BMI, the null hypothesis (there was no 
difference in disease biometrics outcomes in patients with metabolic syndrome following 
implementation of a integrative patient centered provider training protocol) was not 
rejected. Also found, for the training group, the longer length of clinical care received by 
patients (if all other conditions are kept constant) the lower patient’s BMI. This suggests 
that training may have favorable effects on the outcomes, but not large enough to be 
statistically significant.  
Data Compilation and Intention to Treat 
One method used to overcome data capture complications was to create the 





or invalid data from both provider groups creating a whole data set with a total 91 
patients. ITT data is a conservative estimate that is commonly used in clinical research 
when attrition is noted (Gupta, 2011). When comparing the mean value, I examined 
standard deviation and standard error pre and post intervention on the completer data set  
(n = 43), and the ITT data set (n = 91). The difference in means between data sets of 
provider groups (pre and post intervention) showed no significant variation between 
groups and no similarities of either upward or downward trending values.  
The ITT data set had a total of 37 patient data from the provider training group 








Intent-to-Treat Analysis of Biometric Data Between Provider Groups with F Statistic 
 
 
Note .* Significant from baseline at p < 0.05.  
 
 Baseline 




Mean + SD Values 
 
 
F Statistic  
Provider Training Group 
n=37 
BMI  Kg/m2 
HbA1c % 
Fasting Glucose  mg/dl 
Triglycerides mg/dl 
Systolic BP mmHg 
Diastolic BP mmHg 
HDL Cholesterol mg/dl 
 
 
32.92 ± 7.29 
5.98 ± .39 
99.59 ± 11.73 
144.89 ± 79.16 
127.43 ± 14.89 
79.46 ± 12.77 
56.16 ± 18.26 
 
 
31.64* ±  6.84 
5.91 ±  .38 
101.11 ± 16.37 
143.16 ± 64.78 
129.62 ± 16.13 
76.86 ± 14.1 










Non Training Group  
n=54 
BMI  Kg/m2 
HbA1c   % 
Fasting Glucose mg/dl 
Triglycerides mg/dl 
Systolic BP  mmHg 




32.16 ± 6.65 
5.99 ± .88 
105.76 ± 31.08 
150.94 ± 66.31 
131.48 ± 17.52 
82.24 ± 12.98 




5.94 ± .89 
104.52 ± 17.93 
152.19 ± - 61.94 
131.02 ± 15.84 
















 Repeated measures MANOVA was performed with ITT group. Provider training 
Group 1 (intervention) and non training Group 2 (control) as the between subject 
variables and time as the within subject variable, with two time points (pre and post 
intervention). Furthermore, the intervention (integrative patient centered training for 
health care providers) has no statistically significant effect on BMI (Table 7) such that the 
BMI for the patients whose health care providers received integrative patient centered 
training and the BMI for the patients whose health care providers did not receive 
integrative patient centered training did not differ to a statistically significant degree. In 
addition, a statistically significant (p < 0.05) relationship was found between length of 
clinical care for both provider groups and BMI such that (if all other conditions are kept 
constant) the longer the length of clinical care received by a patient, the lower his/her 
BMI. 
Within the ITT data set statistically significant values across time included a 
decrease in BMI in both the provider training group and nontraining group. However, 
similar to the completer data set, there was no statistically significant difference in BMI 
between the training and non-training groups in the ITT set (Table 7). While the 
completer data set suggests possible (but not statistically significance) favorable effects 
of the training, the ITT data set does not. Overall, I failed to reject the null hypothesis 
(there was no difference in disease biometrics outcomes in patients with metabolic 
syndrome following implementation of a integrative patient centered engagement 





The medication adherence research question 2 involved research measurement 
criteria and outcomes data that ended up unreliable and invalid due to the pre intervention 
definition and criteria of “not taking” on the electronic health record not being consistent 
across patient EHRs. Due to this significant discrepancy within the medication adherence 
measurement definition, RQ 2 was excluded. This finding is discussed in Chapter 5. 
Conclusion 
I conducted this study to determine whether integrative patient centered training 
given to health care providers had an influence on patient behavior and health outcomes. 
This potential influence was measured based on two research questions, one addressing 
biometrics and one addressing medication adherence, pre and post intervention training. 
Due to reliability and validity confounding factors, Research Question 2 on medication 
adherence could not be answered.  
The inconsistencies between the two data sets (completer and ITT) may be 
attributed to the current study time frame and sample size limitations. Therefore, the 
"implementation of a patient engagement provider training protocol" has more noticeable 
effect on patients’ biometric outcomes with MetS within the completer set compared to 
the ITT data set.   
For research Question 1, analysis of completer and ITT data sets showed there 
was no statistically significant difference of biometric outcomes, that means I failed to 
reject the null hypothesis, and conclude that based on the current data and available 
information there is no difference between the training and the non-training provider 





Chapter 5: Discussion, Recommendations and Conclusion 
The purpose of this study was to determine whether integrative patient centered 
training for health care providers influenced how patients understood and took care of 
their personal state of health (patient engagement), thereby improving their health 
outcomes. These health outcomes were measured through assessing bio data of patients 
with metabolic syndrome (MetS). Specifically I analyzed their chronic disease biometrics 
(triglycerides, fasting glucose, HbA1c, BMI, high-density lipoprotein, BP) and 
medication adherence. In this chapter I explain the data capture challenges including 
medication adherence analysis, data collection, and sample size attrition. Two areas of 
significance are discussed regarding the outcomes data: a decrease in body mass index 
and an increase in hyperglycemia. Demographics and the reasons why age ranges instead 
of specific ages were used are explained. In addition, current trends regarding MetS, 
provider training and education, and health care and delivery models are explored. I also 
examined how these trends may lead to facilitating social change and its relationship with 
the dynamic health care environment including how trends are both the drivers and 
outcomes of ongoing social change. Limitations of this study are examined to better 
understand the challenges and their impact. I address the latest research and lack of 
research on the effectiveness and efficacy of training providers to improve patient health 
outcomes. In conclusion I consider recommendations for further research and discuss 





Discussion: Data Capture, Significant Outcomes, Trends,  
Social Change, and Limitations 
Data Capture Challenges 
This study had two research questions; Research Question 1 (RQ1): Is there a 
difference in disease biometrics outcomes (blood pressure (systolic and diastolic), 
triglycerides, body mass index (BMI), blood glucose (HbA1c and serum), and high 
density lipoproteins) in patients with MetS following implementation of a patient 
engagement provider training protocol; and Research Question 2 (RQ2), is there a 
difference in medication adherence (EHR noted or reported by patient) in patients with 
MetS following implementation of a patient engagement provider training protocol? 
The capture challenges for RQ1 included multiple confounding factors such as no 
control or incentives for facilitating patient return for appointments, and no control over 
patients following up on appointments with a different provider. The capture challenge 
for RQ2 was that the definition of medication adherence and the term “not taking” on the 
electronic health record were not applied consistently across patient EHRs which in turn 
negatively impacted outcomes data making it unreliable and invalid.  
Research Question 1: Bio Data and Data Capture Challenges 
Challenges in collecting patient data occurred at the 3-4 month point post 
intervention training. One challenge was patients returning for a follow-up appointment 
did not always return to the original provider group they were initially assigned, thus 
making their post-intervention data invalid. Out of 91 patients, 11 saw a different 





group while disregarding their actual post intervention data, this supported the integrity 
of the provider group while maintaining a higher sample size. Allowing this ITT group to 
be created disallowed the attrition factor that would have eliminated 11 patients’ data or 
having 8.27% of patient data unusable.  
A second challenge centered on providers not ordering and collecting all research 
biomedical labs previously captured for their baseline data. Triglycerides, fasting blood 
glucose, HbA1c, HDL cholesterol, BMI, BP, and patient reported medication adherence 
were initially captured. Attempts were made after 3 to 4 months post intervention to 
capture the same data; however, the provider did not always request some of these labs, 
or if labs were requested they were not always completed by the patient. This brought the 
total number of patients with complete data (all biometrics from both the initial baseline 
capture and post intervention capture) to 13 patients from provider training group and 30 
from nontraining group.  
A third challenge was that some patients did not return for a 3-month follow-up 
appointment; therefore, no post intervention data were available. This lack of data and 
high attrition rate had a significant impact on the ability to effectively analyze and 
produce reliable and generalizable outcomes. However, creating the ITT data set and 
bringing initial values forward allowed for the intervention group to remain at 37 and the 
nonintervention group to remain at 54.  
Research Question 2: Medication Adherence and Data Capture Challenges 
At the onset of protocol development, the electronic health record medication 





medication and was noncompliant with doctor’s orders. When post intervention outcomes 
data were collected, I observed that the “not taking” EHR note for medications 
sometimes referred to the medication not being taken were actually replaced by a similar 
but not identical medication for the same condition, and all within doctor’s orders. Upon 
further scrutiny and discussions with the physicians, I learned that “not taking” could 
have various meanings. It could mean that the physician stopped the prescription or the 
patient decided it was not indicated. For example, if it was a pain medication, the patient 
took it only as long as needed; the patient could stop based on his or her own volition, 
and it would later be discontinued by the physician in the EHR. Another example, a 
patient was prescribed a different medication for the same condition due to various 
reasons, and then the originally prescribed medication was listed as not being taken, 
instead of stating that it was switched due to allergy, expense, not effective, or other 
reasons that complied with doctor’s orders.  
The original understanding and definition given for “not taking” and what was 
discussed in Chapter 3, was, patients who decided not to take his or her prescribed 
medication for his or her own reasons and without physician consent. If this definition 
was consistent for every “not taking” note in the EHR medication note, then accurate data 
could have been collected and it could have been discerned that medication not taken was 
due to the patient making the decision without consult with his or her physician. 
However, as described above, that was not the case. 
Due to the inconsistent application of this definition for the medication adherence 





instrument of measurement was neither reliable nor consistent, and results would have 
been skewed and/or completely inaccurate. Therefore, Research Question 2 and the 
associated data were excluded from this study. 
Significance of Outcomes Data 
Intention to treat group (ITT). Only time had a significant effect on one 
dependent variable (BMI). BMI decreased significantly over time in both the ITT 
provider groups. The ITT data set demonstrated a slight decrease of BMI between the 
intervention and control provider groups, but it was not statistically significant. In 
addition, there was no statistically significant differences between within subjects (time) 
or between subjects (groups) with the other dependent variables (disease biometrics).  
The ITT provider training Group 1 (n = 37) demonstrated a statistically significant 
(p < 0.05) decrease in BMI from 32.9 ± 7.2 Kg/m2  to 31.6 ± 6.8 (Table 7). The non-
training Group 2 (n = 54) demonstrated a statistically significant (p < 0.05) decrease in 
BMI from 32.2 ± 6.7 Kg/m2   to 31.5 ± 6.3 Kg/m2  (Table 7). Although statistically 
significant reduction in BMI was observed with ITT data, no statistically significant 
difference was observed when comparing the training and non-training groups to assess 
the effects of the training on patients’ BMI.   
Completer Group. Time and training has a statistically significant p < 0.05 effect 
on body mass index (BMI). BMI decreased significantly over time and but there was no 
statistically significant difference between the training groups. Also, time has a 
statistically significant p < 0.05 effect on fasting glucose in both provider groups.  





99.00 ± 12.84 mg/dl to 104.46* of ±  20.12 mg/dl (Table 6) and non-training Group 2 
(n=30) demonstrates an increase in fasting glucose from 101.33 ± 13.40 mg/dl to 105.47* 
± 18.60 mg/dl (Table 6) and (F (1,4) = 4.28, p < 0.05. It was noted that glucose increased 
over time in the completer data set but not in the ITT data set. This fasting glucose 
finding has no impact on the study due to no statistically significant differences between 
study groups.  
The completer data set shows there is no statistically significant difference p > 
0.05 with BMI between provider training groups (n = 13). Within the provider training 
Group 1 BMI decreases from (35.14 ± 7.86 Kg/m2  to 33.65 ± 7.62; Table 6) however, 
with nontraining provider Group 2 there was no statistically significant (p > 0.05) change 
(32.4 ± 6.62 Kg/m2 to 32.4 ± 6.5 Kg/m2; p = 0.469; Table 6). Therefore "implementation 
of a patient engagement provider training protocol" has no statistical significance on 
disease biometrics outcomes in patients with metabolic syndrome within the completer 
data set. 
Discussions on Outcome Findings 
According to the annual American Health Association (AHA) assessment for 
2015, hyperglycemia and waist circumference have been increasing and trending upward; 
however, high triglycerides and blood pressure have been decreasing (Mozaffarian et al., 
2015). The hyperglycemic data from the AHA study aligns with these outcomes; 
however, no details as to why this may be occurring have been determined. Factors that 
may influence fasting glucose values and ability to compare values reliably, include not 





Decreased BMI levels in both groups were most likely attributed to the treatment 
approach for MetS patients, and in this case a specific focus on obesity and prediabetes. 
All but two patients who had a decrease in BMI also had elevated HbA1c and/or elevated 
glucose levels and were most likely being treated for prediabetes as well as obesity. The 
two patients who did not have elevated HbA1c were borderline high glucose with 5.5 
mg/dl, and for fasting glucose had levels 95 and 85 mg/dl. The standard treatments for 
obesity and prediabetes include increased physical activity, diet low in sugar and fatty 
foods, behavior and lifestyle changes, and in more resistant cases prescription weight loss 
medication, weight-loss surgery, and diabetes medication (American Diabetes 
Association, 2016; Mayo Clinic, 2016; NHLBI, n.d.). Patients who had elevated BMI 
were most likely treated for prediabetes and were put on a more aggressive treatment 
approach that may have led to a decrease in BMI for both groups. 
Tae-Young Pak, Ferreira, and Colson (2016) found that BMI and incidence of 
obesity are still increasing steadily in the United States and are population-wide issues. 
However, certain demographics showed an increasing prevalence of obesity including 
Hispanics, Blacks, elderly, and females (Campbell et al., 2016; Krueger, Coleman-
Minahan, & Rooks, 2014; Tae-Young Pak et al., 2016). Health care costs increased 
significantly when BMI went from Class 1 obesity (30 ≤ BMI to < 35) to Class 2 and 3 
(BMI ≤ 35) (Cawley, Meyerhoefer, Biener, Hammer, & Wintfeld, 2015). Keeping 
obesity levels at Class 1 or lower where health care costs are not rising means lower 





al., 2015; Tae-Young Pak et al., 2016). A small decrease in BMI if held constant or 
maintained would reduce health care costs and improve health outcomes. 
Demographics 
The demographics were analyzed by age range and not specific age based on 
previous National Health and Nutrition Examination Surveys (NHNES) that included a 
meta-analysis using this age range approach within the metabolic syndrome patient 
population. To have comparable measures of age, age range was collected and assessed. 
My data showed a downward trend in MetS symptoms from the 46-60 age range to the 
61-75 year range, which was opposite from the National Health and Nutrition 
Examination Survey (NHANES) 2002-2006 report, which indicated approximately 34% 
of adults over 20 years met the criteria for metabolic syndrome and that it increased with 
age and body mass index (Ervin, 2009). The reason for this difference may be my smaller 
sample size, or that the MetS population may be reversing symptoms and becoming 
healthier since 2009. However, a follow-up assessment by NHANES in 2015/2016 has 
not been published. 
Trends in Metabolic Syndrome 
According to Aguilar, Bhuket, Torres, Liu, and Wong (2015), metabolic 
syndrome prevalence from 2003 to 2012 has been stable. However, it is still a significant 
issue on many fronts with 35% of adults and 50% of adults over 60 having MetS (Aguilar 
et al., 2015). Possible improvements in MetS may be associated with greater patient 
awareness and closer attention to lifestyle behaviors (Aguilar et al., 2015; Beltrán-





more time to understand and collaborate with their patients on better lifestyle choices, or 
patients independently choosing a healthier lifestyle. The reasons are difficult to identify. 
Part of this difficulty may be attributed to pharmaceuticals that control symptoms like 
high blood pressure and hyperglycemia, so lifestyle choices and behaviors may not have 
changed but medication adherence may have improved. Also, not having reliable data to 
accurately compare patient’s data to another’s is an ongoing challenge due to how MetS 
symptom values are defined, how MetS is defined, and how improvements are defined 
(e.g., does better health mean better bio values, better quality of life described by 
patients, or a combination?).  
Though improvement in MetS is the goal for a healthier population and reduced 
health care costs, according to a NHANES report (2002-2006) 34% of the total 
population still have MetS. The burden on patients and their quality of life, including 
finances, still needs focused attention, research, and ongoing dynamic solutions. In 
addition, the extreme burden on the U.S. health care system is requiring millions of 
dollars not only to treat the MetS patients with medications and therapies but to bear the 
burden of caring for those too sick to maintain an at-home sustainable lifestyle (Beltrán-
Sánchez et al., 2013; Cawley et al., 2015; Mozaffarian et al., 2015).  
Trends in Training Providers 
Provider-centric strategies. According to the American Health Association’s 
2015 statistical update the following areas of provider centric strategies are an ongoing 
focus in the efforts to prevent and treat cardiovascular and associated comorbid 





(those with MetS and at greater risk of serious and costly chronic conditions) 
(Mozaffarian et al., 2015). These areas are defined by the Institute of Medicine (IOM) 
using six domains, and include shaping health care systems to incentivize and facilitate 
provider efforts to improve not only the health factors (e.g., bio markers of MetS) but 
also the health behaviors of their patients. The IOM reports that supporting healthy 
behaviors such as nutrition and increased physical activities is essential especially with 
those at greater risk of developing a more serious chronic conditions, such as those with 
MetS (Dickerson et al., 2011; Mozaffarian et al., 2015;Spieker et al., 2015). Training 
health care providers in understanding and applying patient centered approaches to 
patient care can be part of this health care system’s approach to reach its goals of 
improved patient wellness.  
Training within academia. Patient centered team based care with a focus on 
quality and safety has been a dedicated movement within the health care industry and 
highlighted by the Institute of Medicine Report Crossing the Quality Chasm (Institute of 
Medicine, 2001). This report helped drive improvement within the medical education 
system and development of Entrusted Professional Activities (EPA) that translate 
competencies into medical practices. It takes into account knowledge, skills and attitudes 
across the work a family physician performs and the competency domains they are 
required to integrate (AMA. n.d.; Bhuyan et al., 2014; Shaughnessy et al., 2013). It also 
aligns with follow-on continuing education and keeping the provider aware of and 
integrating the latest needs in health care and delivery. This focused structured training 





sciences, working with health care delivery systems in novel ways, making technology 
work for learning, envisioning master adaptive learner, and shaping tomorrow’s leaders; 
it encompasses concepts of team-based care, patient provider engagement and efficiency 
of systems and assumes another building block to provider’s initial and ongoing 
education (AMA, n.d.; Bhuyan et al., 2014; Shaughnessy et al., 2013).  
Efficacy of provider training to improve health outcomes. Training health care 
providers is used successfully in other areas of patient population’s treatment and care 
but limited research is found within the MetS population. Patient populations such as the 
disability population (Iezzoni & Long-Bellil, 2012); mental illness (Byrne, Willis, Deane, 
Hawkins, & Quinn, 2010; Caruso et al., 2013); pediatrics (Jacobson & Gance-Cleveland, 
2011; Xiang, Wethington, Onufrak, & Belay, 2014); and trauma patients (Green et al., 
2015) showed improvements in health conditions where physicians were trained in more 
patient centered counseling approaches. In addition, a study with fibromyalgia patients 
demonstrated providers trained in shared decision making (SDM) had significantly better 
provider patient engagement, however health outcomes did not show improvement 
(Bieber et al., 2006). 
Though not working with specific MetS population, a recent study by the military 
utilized physicians already trained in patient centered medical home approaches who 
focused on obesity prevention in military populations (pregnant women and those post 
boot camp) which showed a positive trajectory of patient health outcomes, however the 
final study is not complete (Spieker et al., 2015). Another study by Ampt et al. (2009) 





Specifically, attitudes of practitioners were described as having an influence over why 
they decided to assess their patients for conditions such as alcoholism. Some providers 
felt certain assessments were to be done only during a formal health check, so many 
health components were not even considered during other clinical appointments. Also 
diet and exercise were sometimes inferred by patient appearance and only addressed if 
overweight. In addition the practitioner’s feelings regarding their effectiveness and 
influence over their patients were considered an attitudinal factor that might impact the 
patient’s motivation towards lifestyle changes (Ampt et al, 2009).  
Specific studies with chronic disease and/or MetS patient populations included 
provider education that focused on including verbal, visual, and written approaches 
which increased the ability to more effectively communicate with their patients (Towner, 
2008). One of the most promising chronic illness studies focused on physician practices 
and medical home models. The study was based on three national surveys from 2006 to 
2013 and included 538 medical groups and independent practice associations; it stated 
increasing practices’ ability to engage patients and their families in their own care may be 
fundamental to advancing patient engagement (Wiley et al., 2015). Patient engagement 
was my research study’s focus, however the outcomes did not reject the null hypothesis. 
Other research supports the need for increased provider’s ability to improve their 
patients’ engagement (Ampt et al., 2009; Spieker et al., 2015; Wiley et al., 2015). This 
research supports my premise around improving lifestyle behaviors and the patients’ state 





Shared Decision Making (SDM) is a term often used in association with patient 
centered care, patient provider engagement, and other practices that focus on the 
relationship between the provider and patient (Tapp et al., 2014). It is found that 
providers and patients may have different goals for the patient’s treatment and care, and 
without effective collaboration between provider and patients, low or no SDM can lead to 
inadequate chronic pain management (Frantsve & Kerns, 2007; Tilburt et al., 2014). 
The concept and practice of patient centered care is supported through multiple federal, 
state, and local medical and health care associations and their initiatives and policy.  
 These initiatives include the AMA’s new resolutions to promote evidence based 
lifestyle medicine and interventions in treatment of disease as the first primary mode of 
prevention, and a focus on the need for patient centered health care provider training 
(AMA, n.d.). The National Academy of Sciences has five core competencies every 
physician should incorporate: provide patient centered care, work in interdisciplinary 
teams, apply quality improvement, and utilize informatics (Summit, Greiner, & Knebel, 
2003). There are movements and programs throughout the U.S. and other countries 
utilizing numerous methods to advance the patient centered care model. This patient 
centered model and approach, though not standardized in the industry yet, is being 
promoted as a worthwhile model to implement into practice and integrate into the health 
care delivery payer models. The challenges around efficacy and effectiveness includes 
producing evidence-based research showing the benefits to health outcomes and reduced 





In conclusion on trends in training, a meta-analysis that assessed the value of 
medical provider training showed that patient centered training was effective in 
improving providers’ patient centered skills (Dwamena et al., 2012). The effect on patient 
satisfaction and healthy behaviors were mostly positive, however health outcome 
improvements were not consistent. These inconsistent “improved outcomes” were a 
running theme within understanding the effects of patient centered care and provider 
training overall, and support justification of continued research (Ampt et al., 2009; Wiley 
et al., 2015; Spieker et al., 2015; Towner, 2008).  
Trends in Health Care and Delivery Models 
Trends in health care delivery models have emerged from both a grassroots 
patient/consumer driven demand and provider demand to practice more satisfying 
medicine; and a top down policy driven trend facilitated by the Accountable Care Act 
(ACA), AMA, Healthy People 2020, National Prevention Strategy, and Institute of 
Medicine’s Crossing the Quality Chasm. The ACA is facilitating initiatives to improve 
patient experience, health of the population, and reducing costs per capita, called the 
accountable care organization’s triple aim focus. The ACA also includes promotion of 
the medical home model that emphasizes coordination of care and patient satisfaction 
(Daly, 2013).  
The National Prevention Strategy, Healthy People 2020 and the Institute of 
Medicine Crossing the Quality Chasm lay out goals and criteria to get the people of our 
nation healthier and happier; while conveying the urgency to make changes due to the 





(Healthy People 2020, 2014; Health and Human Services, 2016; Institute of Medicine, 
2001). In addition the continued increase of health care costs impact our nation, our 
economy, our businesses, our individual expenses, and quality of life (Daly, 2013). The 
CDC stated the rate of chronic disease such as obesity, cardiovascular, stroke, and cancer 
is increasing and accounts for 75% of our nation’s 2 trillion spent on health care. This 
spending makes chronic disease the lead factor in current health care expenditures, in 
front of technology, prescription drugs and administrative costs (CDC, 2011; Kaiser, 
2012). The above trends reflect both the outcomes and the drivers of social change in our 
dynamic health care environment; from patient and provider satisfaction, to decreasing 
health care costs, to federal policy development focused on disease prevention, patient 
centeredness, and equitable treatment reimbursement. 
Social Change  
This study has a critical mission, to assess the effects of patient centered 
integrative provider education and clinical practice application with their MetS patients 
through identifying if training influenced patient engagement behaviors and thereby 
medication adherence and health outcomes. It provides a basis for an innovative, 
effective inspiring model of health care and delivery based on promoting healthy provider 
patient relationships in order to facilitate patient engagement and gain positive health 
effects. However what may faciliate the greatest social change is simply working towards 
understanding what matters most to patients in order to motivate positive lifestyle 
behaviors and allowing providers the time and reimbursement to practice patient centered 





Training health care providers specifically in the conceptual and practical 
application of integrative patient centered engagement can in turn help the provider 
maintain a satisfying practice. As this component of health care and delivery is 
understood, delineated, and correlated with improved patient engagement it may be an 
additional practice that gives providers requisite skills to empower their patients towards 
motivated self health care and medication adherence and the provider towards a more 
fulfilling practice. This approach to understanding and incorporating new health care 
practices is a paradigm shift in the U.S. and represents social change.  
Overall this study reflects social change on two fronts, positively influencing 
quality of life for both the patients and providers. If patients’ overall health improves and 
there is less need for medications, emergency procedures, and chronic disease care then 
health care costs for these conditions will presumably decrease. Social change for this 
research revolves around patients feeling better and becoming healthier based on the 
providers’ ability to engage their patients and influence positive behavioral changes. 
Specifically, health care training that provides conceptual and practical application of 
integrative patient centered engagement tools may support individual patient engagement 
health behaviors that in turn may positively impact MetS symptoms. These social 
changes have the potential to improve health outcomes, reduce chronic disease, decrease 
health care spending and improve the overall life of those suffering with MetS and those 






The quality of bio data outcomes may have been impacted by multiple factors to 
include labs not being taken at the same time of day and under the same conditions such 
as fasting. Medication adherence data were found to be unreliable due to the original 
definition and criteria of “not taking” on the electronic health record not being consistent 
across MetS patient EHRs. This significant discrepancy within the medication adherence 
measurement instrument necessitated Research Question 2 and its data to be excluded.  
The sampling size significantly diminished from a 515 to 91patient data due to 
initially filtering MetS patients on three of the six dependent variables (triglycerides, 
HDL, and BP), when first assessing the sample environment; then filtering utilizing the 
remaining three variables (fasting glucose, HbA1c and BMI) to obtain the research 
sample. In addition, capturing post intervention data were limited by patients not coming 
back for their follow-up appointments, not getting provider requested labs, and patients 
not having their follow-up clinical visit within their original provider group. The sample 
size did not meet the minimum requirement of 125, even with establishment of the ITT 
data set.  
Another limitation revolved around the term patient engagement and the various 
definitions still used within the health and medical industry. Even though this research 
was based on the combined definitions from the Agency for Healthcare Quality and 
Research (AHQR) and Simmons et al, (2014)’s systematic review study, the literature 
review and in depth research had to involve numerous other related terms in order to 





and information that did not meet definition criteria, and extrapolating from the literature 
pertinent information necessary for understanding and performing this research.  
In summary, biometric limitations included knowing if a patient had fasted and 
performed labs at a certain time of day, which may be a challenge for any similar 
research protocol. Filtering sample size by all variables under study is a process that can 
be performed in the future for more precise initial sample data numbers. Also, 
understanding how medication adherence is defined and understood across all patient 
medical records and medical scenarios would facilitate greater use of this impactful 
health factor. Overall, the most challenging limitations around this patient engagement 
study was defining and utilizing the term patient engagement. Further refinement and 
research must be conducted in order to establish a consistent generalizable term that can 
be used reliably across the industry in research, academia, and clinical practice. 
Recommendations  
Recommendations for further research around patient engagement and medication 
adherence are indicated from this study. Although my medication adherence research 
could not be utilized, the current negative impact on health and finances due to 
medication noncompliance strongly suggest further research is warranted. In addition, 
based on my review and research of patient engagement and provider training, 
specifically within the MetS patient population, there are significant health benefits and 
knowledge to be gained from follow-on research.  
The population’s health and wellbeing in the U.S. is benefiting from this 





reactive health care system to one based on prevention, whole-person health, and 
collaboration. Metabolic syndrome patients engaging in their care and healthy lifestyle 
choices is essential to improved health and better quality of life; and providers practicing 
compassionate effective care will continue to be a contributing factor. As the Patient 
Centered Outcomes Research Institute and the Agency for Healthcare Research and 
Quality develop models, frameworks, and approaches that align provider training with 
reliable and patient centered approaches, follow-on research can be conducted producing  
evidence-based outcomes that will be understood and incorporated throughout the health 
care system. Through incorporating evidence based models of integrative 
patient/family/community centered care, improved population health and exceptional 
individual quality of life can be achieved. 
Conclusion 
This study assessed the effects of a patient engagement provider training protocol 
on patient engagement and whether there was an effect on patient health outcomes and 
medication adherence. Due to validity and reliability issues medication adherence could 
not be assessed. Two groups of patients were compared, those that had clinical visits with 
providers trained on integrative patient centered care (intervention group), and providers 
not trained on integrative patient centered care (control group). Two areas of literature 
were used to define patient engagement for this research. First, patient engagement 
defined by the Agency for Healthcare Quality and Research (AHQR), “an ongoing 
process in which patients take an active role in their own healthcare” and involve factors 





effectively engage in care” (AHRQ, 2011, p.1). Second, Simmons et al. (2014) used the 
definition in their systematic review of clinical trials on patient engagement as (a) 
understanding the importance of taking an active role in one’s health and health care; (b) 
having the knowledge, skills, and confidence to manage health; and (c) using knowledge, 
skills and confidence to perform health-promoting behaviors (p. 3). Together these 
definitions shaped and drove the research. 
There are many approaches and techniques used to describe new and old ways to 
develop “bedside manner” in order to improve the relationship between provider and the 
patient to support patients in their lifestyle behavior choices. Patient centered techniques 
in the field include: shared decision making (SDM), SHARE by NCQA, motivational 
interviewing, facilitating congruence, collaborative care, patient provider symetry, 
participatory medicine, relationship centered care, building healing relationships, patient 
centered care, teach back, health literacy awareness, and others (Barello et al., 2012; 
Bertakis, Klea, 2011; Cox, 2011; Gionfriddo et al., 2014; Jackson, Tucker, & Herman, 
2007; Williams et al., 2000). There are multiple models of health care and delivery from 
which to incorporate these techniques such as: patient centered medical home (PCMH), 
accountable care organizations (ACO), community centered health homes, medical/health 
homes and others in our forward progressing health care arena (Daly, 2013; Peek, 2010; 
Rittenhouse et al., 2010). Regardless of the integrative model employed or patient 
centered approach used, at the most fundamental level it is beneficial for providers to 





Provider training was given to promote health care providers’ ability to facilitate 
self-healthy behaviors (patient engagement) with their patients; such as better nutrition, 
exercise, stress management, restorative sleep, pursuit of happiness and medication 
adherence (AHRQ, 2011; Brunton, 2011; Chisholm-Burns & Spivey, 2012; Cox, 2011; 
Engel, 1977; Guarneri & Tager, 2014; Khanna et al., 2012; Simmons, et al., 2014; 
Williams et al., 2000). Eventhough there was no statistically significant relationship 
between provider groups (training/non-training) and patients’ immediate health results, 
many integrative patient centered skills were taught and potentially practiced by the 
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Appendix A: Integrative Healthcare Patient Centered Patient Engagement Training  
 
(Color divides three training sections taught during three separate dates)  
 
  
1. Integrative Patient Centered Healthcare - 
a. Escape Fire Film 
b. Industry definitions  (Clinical, Academia, Research) 
c. NOVA Medical Group definition 
2. Patient Engagement  
a. Definitions in industry 
b. Training definition 
3. Health Literacy 
a. Defined 
b. Necessity (Culturally/Linguistically) 
c. Current Issues/Challenges: Health Disparities 
4. Mission, Vision, Values 
a. Yours  
b. Company’s 
c. Optimal 
5. Your Patient Engagement Style 
a. Emotional Intelligence 
i. Your role in prevention and health promotion (knowledge & 
attitude) 
ii. What you do well 






c. Building Awareness 
i. Building Healing Relationships 
ii. Motivational Interviewing 
iii. SHARE Approach 
d. Limitations, Challenges, Obstacles 
i. Enough time with patients 
ii. Clinical inertia 
e. What Motivates you 
i. Job well done 





iii. Patient feedback (to provider and public/work recognition) 
f. Your optimal Patient Relationship 
 
6. Patient Intake & Application 
a. Questions & Comfort Level (lifestyle, intimacy, nutrition, family 
health history/relations) 
b. Shared Decision Making (SDM) 
c. Educating /Motivating Patient (understanding main issue, treatment  
& personal goals, follow up at 1-3 months). 
d. Electronic Health Record Integration 
e. In house referrals and complementary therapists  
f. Working as an integrated team (processes for) 









Q Integrative Healthcare LLC & 
Northern Virginia Veterans Association, 501(c)3 
 
Angela@IntegrativeHealthVA.com & President@NovaVets.org  
 
OWNER / CONSULTANT 
COMMUNITY SOLUTIONS 
 
Developing & Collaborating to Establish Patient Centered Healthcare  
Innovative business leader experienced in implementing collaborative community health 
partnerships and integrative patient centered care programs and policies for the healthcare 
community. Experience includes working with public/private medical centers, 
Veteran/military programs and initiatives, academic institutions and information 
technology systems. 
 
Leadership experience across all levels of healthcare and military with emphasis on 
management, patient centered care, quality, safety, workflow efficiency and multi-site 
operations. Expert in identifying gaps and needs in healthcare, understanding how to 






Lead Industry Speaker ≈ National Summits, Hospitals, DoD Centers of 
Excellence, Chambers of Commerce, Congressional Councils, Veterans Service 
Organizations, Departments & Associations & Public Health Initiatives 
Chairperson ≈ Prince William Chamber of Commerce Health Council 
Board of Directors / Advisor ≈ Providing insight and expertise to agencies 
and organizations on veteran and health-centric issues 
President/CEO and Founder ≈ Northern Virginia Veterans Association 
 
PROFESSIONAL EXPERIENCE 
Q Integrative Healthcare LLC Owner, Woodbridge, VA, 
2009 – Present. 
Integrative Healthcare subject-matter expert providing consultation and support. 
Strategic development of collaborative community-wide health/medical/wellness 
partnerships. Consulting, creating and implementing integrative healthcare 
infrastructure, programs and policies. Utilizing leading-edge research, analytics, and 
innovation to create efficient collaborative health systems focusing on improving health 
outcomes, reducing costs and sustaining a culture of continuous improvement.  
 
 Leads healthcare stakeholders in resource sharing and partnerships as 
Chairperson, Prince William Chamber Health & Wellness Council. Focused is 
placed on local, state and federal policy issues, workplace wellness and 
healthcare reform. Stakeholders include hospital systems, medical providers, 





 Partnered with ABC 7 and United Way on multi-media Veterans Hiring 
Campaign. Provided support in developing, organizing and networking nonprofit, 
government & private sector organizations to determine employment challenges 
in order to provide a continuum of services in support of Veteran/family success 
across National Capitol Area.  
 Developer and instructor of continuing education on integrative healthcare and 
community collaboration topics that include: integrative healthcare models, 
integrative patient centric practices, trauma/post traumatic stress disorder, 
military culture/ medical resources, workplace wellness and community 
partnerships/networks. 
 
Northern Virginia Veterans Association (Founder) 
President/CEO (Jan 2015 – Present) 
Local Resources to Support Our Local Veterans. Founded and began developing 
NOVA Veterans in 2013. It has a distinct and necessary mission being a hands-on, non-
profit that connects veterans & military families, at no cost, to a vast system of 
community resources addressing needs to support & improve their quality of life. This 
service organization is different such that it provides a comprehensive continuity of 
support, follow-up and case management. It is not a referral agency nor navigation 
service, but a quality control organization that coordinates support through select 
trusted partners. Through this structure our partners connect and learn about each other, 
breaking down the silos in order to build a responsive, efficient and caring community.  
 
 Founded because no other organization was providing guidance, comprehensive 
support and case management through this complex and confusing web of 
services 
 Nationally almost half of veterans surveyed didn’t know how to get the services 
and benefits they deserve and have earned 






On-going veteran & community awareness to action campaigns for Northern Virginia, to 
provide information and resources: 1) Determining local veteran resources, 2) Identifying 
local veteran needs and creating solutions, 3) Providing a rally point for veteran 
volunteers to support other veterans in our local community, 4) Performing widest 
veteran outreach & support. www.novavets.org 
 
Consultation & Capture Management Medical/Healthcare 
(2012/2013) 
Provides comprehensive contract management capture, proposal strategy, and 
comprehensive subject matter expert support for Applica Solutions (SDVOSB). 
 
New Business Consulting / Business Development 
(2011/2012) 
Provides innovative policy and program infrastructure for the National Aesthetic 
Accreditation Agency, the first medical aesthetic accreditation agency. Integrates new 
state regulations to support legal, safe, quality standards for all medical aesthetic 
practices. Incorporates transparent competitive marketing with a patient centered focus.  
 
Counter Terrorism/Force Protection Reserve Officer (June 
1994 – July 2009 retired) Major, United States Air Force Europe, Ramstein 
Germany. Provided integrated, multi-discipline intelligence to satisfy warfighter 
requirements for all phases of military operations. Monitored and analyzed activities in 
conjunction with military/political crisis situations. Developed strategic mission-essential 






Project Manager FDA (May 1991 – May 1993) Ebon Research 
Systems: Food and Drug Administration, Laurel MD. Managed and lead thirty plus 
biomedical research employees in new bio-hazardous facility. Prepared and 
implemented all standard operating procedures covering personnel, biohazard 
regulations, research materials and equipment. Ensured research protocols, personnel, 
and facility complied with federal, state and local laws, policies and regulations. 
 
Manager/Technologist – U.S. Army Active Duty (January 1987 – May 1991) 
Sergeant, Walter Reed Army Medical Center / Armed Forces Institute of Pathology 
Washington D.C., biomedical research support. Uniformed Services University of the 
Health Sciences Bethesda MD, managed critical research division. Practiced and 
directed technologists on procedures for research protocols. Supported and educated 
investigative staff and medical student body in medical / surgical procedures and 
techniques. (Inactive Ready Reserves June 1991-May 1994). 
 
EDUCATION 
 Walden University, PhD Health Administration Candidate, 2016  
 Ohashiatsu Institute, Shiatsu Acupressure Graduate, Nov 2004 
 Troy University, Masters of Public Administration, Dec 1999 
 University of Maryland, B.Sc. Microbiology, July 1992 
 
BOARD OF DIRECTORS & PROFESSIONAL ASSOCIATIONS 
 George Mason University College of Health and Human Services Advisory 
Board 






 Board of Director Virginia Alliance of Information and Referral Systems 
 Board Veteran Advisor to the Prince William County Government Area on 
Aging 
 Military Officer Association of America & Reserve Officers Association   
 Prince William Chamber of Commerce: Health & Wellness Council, 
Government Affairs, Veterans Council, Nonprofit Council 
 
AWARDS AND DECORATIONS 
 NOVA Veterans Assoc., Prince William Living Giving Back Award – 1st 
Runner Up 2015 
 2015 Catherine Spellane Citizen of the Year, Dale City Civic Association 
 Prince William Chamber of Commerce Business of the Year 2013 
 President’s Volunteer Service Award from the President’s Council on Service 
and Civic Participation 2009 
 USAFE Outstanding Air Reserve Field and Company Grade ISR Officer of the 
Year  (Jan 2007, Jan 2006, and Jan 2003) – Awarded for outstanding 
leadership and exemplary improvements to war fighting capabilities 
 Meritorious Service Medal – Awarded 9 Sept 2005 for distinguished 
meritorious service as Counter Terrorism Analyst, United States Air Forces in 
Europe Theater Air and Space-operations Center, Germany 
 
CLUBS/ACTIVITIES 
 Team Red White & Blue (Veterans/Military Health and Fitness) & Ride to 
Recovery (R2R) 
 Ballroom / Latin Dance  
 Bikram Yoga / Triathlons 





SPEAKER, VOLUNTEER, EDUCATOR, INNOVATOR 
 Monthly speaking engagements to include: 2016, Area on Aging, veteran 
panels, healthcare panels, Prince William Chamber Medical Panel on 
Innovation (July 2015) 
 Military Culture & Healthcare Resources Training – Hospitals, Clinics, Medical 
Providers 
 Association for Defense Communities National Summit - Expert Panel 
Speaker on Medical Community Partnerships (June 2014); 
 Chamber of Commerce Speaker and Moderator multiple events (2011-
Present) 
 Wounded Warrior Mentor Program: Serving wounded warriors and their 
families, Fort Belvoir, Quantico, Walter Reed Bethesda (Jan 2011 - Present) 
 DCoE Psychological Health & Traumatic Brain Injury: Air Force Reserve, 
briefed and advised leadership on Integrative Healthcare and its 
comprehensive application and benefits to the military (July 2009) 
 Walter Reed Army Medical Center CAUSE/TOR contract coordinator for 
Mologne House Grant Program: Hiring, training and providing credentialed 
complementary practitioners for military outpatients and family members (Oct 
2008 – Oct 2009) 
 Army’s Force Health Protection Conference: Developed and presented 
information and education brief on The Benefits of Shiatsu/Acupressure 
Integrative Complementary Therapy for Post Traumatic Stress Disorder 
(Kentucky 2007). 
 
 
 
